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Septicemia is a leading cause of morbidity and mortality among hospitalized 
patients. There are approximately 400,000 cases each year in the United States, and the 
incidence continues to increase (1). It has been estimated that gram-negative bacteremia 
occurs in about 30 percent of patients with septicemia (32). Despite the use of potent 
antibiotics and intensive supportive care, the mortality among patients with gram-negative 
bacteremia remains high, varying from 20 to 60 percent (32,132,231). The common fatal 
cause of overwhelming gram-negative bacterial infection is septic shock, a syndrome 
characterized by inadequate tissue perfusion which ultimately leads to organ failure and 
cellular death (3,97). Pathophysiological changes involve hemodynamic, metabolic, 
neuroendocrine and immunologic alterations (3,252). Clinical manifestations include 
chills, fever, hypotension, decreased vascular resistance, glucose dyshomeostasis, 
lactacidemia, and the acute phase response. 
Endotoxin, which is composed of lipopolysaccharide and associated proteins from 
the gram-negative bacterial wall, has long been considered to be the principal causative 
factor in the pathogenesis of gram-negative septic shock (103,167). Striking parallels 
exist between the effects of endotoxin in experimental animals and those observed in 
1 
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patients with septic shock (104,122,168,171). Thus, endotoxin-treated animals have been 
extensively used as an experimental septic model. Alternatively, recent experimental 
findings suggest that endotoxin elicits most (if not all) of its pathophysiological effects 
not directly but via stimulating different cell populations to release mediators. These 
mediators, such as prostaglandins (230), leukotrienes (230), platelet activating factor (45) 
and cytokines (78,79,171), have been linked to the pathogenesis of endotoxic shock. 
Among many pathophysiological changes which occur during endotoxic shock is 
markedly increased sympathoadrenal activity which has been viewed as a compensatory 
response of the body to septic challenge (51). Evidence for this activation includes an 
elevation of plasma catecholamines in septic patients and animal models (17,94, 113,115), 
a depletion of tissue catecholamine content in the terminal state (187), and an enhanced 
norepinephrine turnover in certain tissues during endotoxic shock (188). These findings 
have been interpreted as an increased release of transmitters from sympathetic nerves and 
the adrenal medulla. In addition, direct nerve recording has shown augmented 
sympathetic nerve discharges in selective organs of endotoxic animals (92,185), although 
some conflicting results have been reported (127,128). The sympathoadrenal activation 
has been shown to have both detrimental and beneficial effects during the development 
of septic shock (148). In the early stages, plasma catecholamines may support the 
cardiovascular and metabolic adjustments to septic insult. Overwhelming and sustained 
sympathetic activation, however, may contribute to the irreversibility of septic shock by 
restricting nutritional organ blood flow. Even in light of these detrimental effects, 
adrenergic agents have been widely used in patients with septic shock as a treatment to 
3 
support the cardiovascular system (33,50, 141). Although concerns were raised regarding 
local ischemia of vital organs, particularly the kidney as a result of increased vascular 
resistance (33), several recent studies report that norepinephrine therapy improves the 
blood pressure and urine output (43,62, 197). The dual-sided effects of sympathoadrenal 
stimulation in septic shock imply that a better understanding of the mechanisms of the 
sympathoadrenal activation may allow prompt manipulations of the system and facilitate 
the management of sepsis. 
The mechanisms responsible for mediating the sympathoadrenal activation during 
sepsis and septic shock are not clear and remain basically unexplored. The critical role 
of centrally mediated mechanisms and neural dependence in the sympathetic activation 
during developing endotoxic shock has been demonstrated in previous studies 
(71,149,176,253). Recent studies using more sensitive catecholamine assay, however, 
suggest the occurrence of peripheral modulations of catecholamine secretion from the 
adrenal medulla during endotoxic shock (112,211). Evidence of non-neurogenic 
stimulation of adrenal epinephrine secretion was provided by experiments showing that 
ganglionic blockade could not prevent catecholamine release from the adrenal medulla 
in septic animals (211). In vitro incubation of adrenal chromaffin cells with endotoxin or 
other endotoxin-elaborated agents enhanced catecholamine secretion (177,225). 
Another consideration emphasizes that the adrenergic discharge may be primarily 
stimulated by endotoxin-induced systemic hypotension and associated baroreceptor reflex 
deactivation (93,148). However, certain experimental findings challenge this concept and 
suggest that the sympathoadrenal system can still be markedly activated by endotoxin or 
4 
gram-negative bacteria in the absence of significant hypotension (89, 115) and remain 
activated after restoration of blood pressure (185). 
It is now clear that cytokines, a family of protein molecules produced by 
macrophages and other cells, are the key mediators in the pathogenesis of sepsis and 
septic shock. Currently, growing evidence also suggests that cytokines such as 
interleukin- I, interleukin-6 and tumor necrosis factor may mediate interactions between 
the immune and neuroendocrine systems. On one hand, cytokines are produced mostly 
by cells of the immune system and exert many actions during immune responses. On the 
other hand, cytokines have a broad spectrum of actions including influences on 
neuroendocrine functions. Among the cytokine actions, some involve the central nervous 
system and may be initiated in the brain side of the blood brain barrier (107, 118, 194). 
Brain tissues have receptors for and can respond directly to certain cytokines 
(87,107,117,194,250). Furthermore, interleukin-I immunoreactive innervation of brain 
areas was recently reported (34,136). In vivo production of interleukin-I, tumor necrosis 
factor and interleukin-6 in the brain has been demonstrated in infectious and various 
other pathological states (54,82,95,135). In vitro, brain cells have also been shown to 
produce interleukin-I, tumor necrosis factor and interleukin-6 in response to endotoxin 
or virus challenge (138,200). Thus, it is logical to propose that cytokines might be 
plausible factors in mediating the sympathoadrenal activation with endotoxin via their 
central actions. 
Considering the clinical importance of gram-negative bacteremia and septic shock, 
the involvement of the sympathoadrenal system in septic pathogenesis, the reappraisal of 
5 
norepinephrine therapy in septic patients, and unknown mechanisms for the sympathetic 
activation during sepsis, this dissertation was designed to explore some potential 
mechanisms involved in mediating the sympathetic activation, using endotoxin-treated rats 
as an experimental septic model. The specific aims of the following studies include: 1) 
the examination of the overall contributions of central versus peripheral mechanisms to 
the sympathoadrenal response during endotoxicosis, 2) the evaluation of the role of 
afferent neural inputs from arterial baroreceptors in mediating the sympathoadrenal 
activation in endotoxic animals, and 3) the assessment of the effects of centrally-
administered cytokines, interleukin-I, interleukin-6 and tumor necrosis factor, on central 
sympathetic outflow. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
A. SYMPATHOADRENAL ACTIVATION DURING DEVELOPING SEPTIC SHOCK 
I. Evidence for Sympathoadrenal Activation during Septic Shock 
Plasma catecholamines are shown to be elevated in human patients with septic shock 
or serious infection in early stages (17,19,89). In most non-surviving patients, high 
plasma norepinephrine and, to a lesser extent, epinephrine concentrations were sustained 
but fell rapidly just before death (19). This fall is presumably due to either the depletion 
of catecholamines from the adrenal medulla and sympathetic nerve endings or the overall 
failure of the central nervous system. Plasma catecholamines have also been measured 
in a variety of septic animal models (endotoxic, bacteremic, cecal-ligation and puncture 
(CLP)) (112,113,115) and different species (dog, rabbit, cat, and rat) (94,99, 113,218). 
Although the patterns and magnitude of the catecholamine response during 
septic/endotoxic shock varied in these different models, the increases in plasma 
concentrations were frequently demonstrated. For example, endotoxin administration in 
rats resulted in a rapid (within 30 min) and dose-dependent elevation of plasma 
catecholamines, in which norepinephrine elevation was sustained while epinephrine 
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elevation declined with time (114). In contrast, the rat model of CLP had a prolonged 
time course for the increment of plasma norepinephrine which developed hours after CLP 
and remained elevated for 40 hours with only modest increase in epinephrine (126). 
Depletion of tissue catecholamine content has been observed in the terminal state of 
septic shock. Hanquet et al. (96) measured the catecholamine content of the adrenal 
medulla removed from patients who had died of shock and reported a marked depletion 
of catecholamine stores. In different animal species, endotoxic shock was also associated 
with the depletion of adrenergic neurotransmitters in tissues such as heart, spleen and 
adrenal medulla (98,187,254). Pohorecky et al.(195) indicated that such tissue depletion 
was dose- and time-dependent following endotoxin. The depletion is speculated to be due 
to a sustained release combined with decreased synthesis possibly caused by hypoxia and 
acidosis. 
Studies using radio-labeled norepinephrine and subsequent incorporation into the 
existing transmitter pools showed that endotoxin induced a time-dependent decay in 
specific activity of heart and spleen (188). This result indicates an increased 
norepinephrine turnover and, hence, increased sympathetic activity during endotoxicosis. 
Direct recording of sympathetic nerve discharge, in most cases, also revealed an 
enhanced sympathetic nerve activity. In studies with anesthetized dogs and cats, Halinen 
(92,93) demonstrated that endotoxin induced increased discharge of cardiac sympathetic 
efferent nerves 15 min following intravenous administration. Cervical sympathetic nerve 
activity was also found markedly elevated in anesthetized rats following endotoxin (159). 
Using conscious, unstrained rats, Palsson et al. (185) showed that intravenous injection 
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of either endotoxin or bacteria significantly enhanced renal sympathetic nerve activity. 
In contrast to the above findings, Koyoma et al. (127,128) reported that preganglionic 
splanchnic nerve activity and renal sympathetic nerve activity were decreased after 
endotoxin injection in anesthetized cats and rabbits, respectively. It was concluded in 
their studies that endotoxin treatment inhibited the central sympathetic outflow. 
Collectively, a large body of literature can be found regarding the sympathoadrenal 
activity during the development of septic shock and the demonstrations of its activation 
in septic processes have been convincing and generally accepted. More thorough review 
of this topic can be found elsewhere (186). 
II. Effects of Sympathoadrenal Activation during Septic Shock 
The sympathoadrenal system appears to be critically important, if not essential, in 
maintaining life in the early stage of endotoxic shock in animals. Endotoxin treatment in 
rats with adrenal demedullation or/and chemical sympathectomy are usually associated 
with rapid onset of death and markedly increased mortality (131,156). Those animals 
often have a very rapid and more profound fall in blood pressure and attenuated 
tachycardia. This result suggests that both sympathetic and adrenal catecholamines 
contribute importantly to the maintenance of arterial blood pressure and cardiac output 
during endotoxicosis. Catecholamines are known to increase ventricular contractility, 
which improves cardiac output, and mobilize liver glycogen to support increased tissue 
metabolism during endotoxin shock (77, 125). 
On the other hand, the detrimental effects of the sympathoadrenal activation during 
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the development of endotoxic shock have also been suggested. Blunting of the excessive 
sympathetic activation has been shown to protect against the shock pathogenesis (31,88). 
For example, Lillehei and Maclean (140) pretreated dogs with alpha adrenergic 
antagonist to block the vasoconstrictor effects of catecholamines released during 
endotoxicosis. They found that this pretreatment significantly improved the survival rate 
(84% lethality with endotoxin alone, 0% lethality with endotoxin and alpha blockade, 
measured 72 hours after endotoxin) and alleivated the pathological changes. Filkins also 
reported that alpha adrenergic blockade (phentolamine) protected rats against endotoxin 
shock lethality and blunted the development of endotoxic hypoglycemia. In isolated 
hepatocytes, alpha blockade protected against endotoxin-induced depression of hepatic 
gluconeogenesis (76). 
Exogenous catecholamines have been widely used in patients with septic shock to 
support the failing cardiovascular system (33,50,139). Dopamine is particularly indicated 
for treatment of patients with oliguria and decreased peripheral resistance. The use of 
norepinephrine in septic patients is controversial due to the concerns regarding organ 
ischemia as a consequence of diffusive vasoconstriction (33). However, interest in the 
therapeutic use of norepinephrine has recently been reported (43,62, 197). Particularly in 
septic patients with high cardiac output and low peripheral resistance, norepinephrine 
treatment improved blood pressure and renal function without deleterious effects on 
cardiac index, oxygen delivery and oxygen consumption (197). 
A generally accepted view (148) is that in early phases of septic shock, the 
sympathoadrenal activation may be beneficial by virtue of vasoconstriction in non-vital 
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h. ch favors the perfusion of more vital organs. Excessive sympathetic activation organs w 1 
be detrimental in the long run by restricting nutritional blood flow which ultimately may . 
leads to severe metabolic and circulatory failure. Unfortunately, we still are unable to 
determine with adequate precision when an increased sympathetic tone is no longer 
beneficial during the developing septic shock. 
B. REGULATION OF THE SYMPATHETIC NERVOUS SYSTEM 
I. Spinal Cord Control 
The traditional concept that the spinal cord serves solely as a relay station for 
transmitting information from the medulla to postganglionic neurons innervating the 
cardiovascular system is no longer tenable (14). Several observations indicate that 
information processing in spinal neural circuits can be an important determinant of the 
level of sympathetic control of the cardiovascular system. In animals with maximal 
reduction of blood pressure and sympathetic nerve discharge by medullary transection at 
the level of the obex, secondary section of cervical cord induced increases in sympathetic 
nerve discharge (7). This implies that the final output from the central nervous system 
to the circulation can be modulated by neurons in the spinal locus. Activation of somatic 
and visceral afferent fibers produces reflex responses in sympathetic nerves which do not 
require the integrity of bulbospinal pathways (207). Furthermore, blood pressure can 
gradually return towards control levels and prominent cardiovascular reflexes can be 
elicited in chronic spinal animals and man (14). Local intemeurons have been shown to 
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exist in the intermediate gray matter of the spinal cord which innervate the sympathetic 
preganglionic neurons at all levels of the sympathetic outflow (14). The presence oflocal 
intemeurons implies that there are additional descending and intrinsic spinal pathways 
that indirectly control the sympathetic outflow, but relatively little is known about these 
pathways. 
II. Supraspinal Control 
Several interconnected central networks regulate the sympathetic outflow. The 
incoming afferent fibers carrying visceral sensation from all the major organs of the body 
including the cardiovascular system primarily terminate in the nucleus tractus solitarius 
(NTS), the most important visceral sensory relay cell group in the brain stem. From 
here, information is sent via intemeurons either to a number of key nuclei in the brain 
stem which project directly to autonomic preganglionic neurons of the sympathetic and 
the vagal systems or to the forebrain nuclei in the central autonomic network that are 
capable of regulating both autonomic and neuroendocrine functions (143). Reciprocal 
pathways between the NTS, the brain stem nuclei (ventrolateral medulla, the A5 cell 
group, the parabrachial nucleus) and forebrain areas (the paraventricular hypothalamic 
nucleus, the bed nucleus of the stria terminalis, and the central nucleus of the amygdala) 
are the anatomical substrates for sympathetic regulation (143). Direct projections to the 
intermediolateral cell column, where the sympathetic preganglionic neurons are located, 
have been demonstrated to originate from seven areas of the brain (147,223): 1. the 
rostral ventrolateral medulla, 2. the caudal raphe nuclei (raphe pallidus and raphe 
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obscurus), 3. the A5 noradrenergic cell group, 4. the Kolliker-Fuse nucleus, 5. the 
paraventricular hypothalamic nucleus, 6. the lateral hypothalamic areas, and 7. the 
central gray matter. 
m. Central vs. Peripheral Involvement in Sympathoadrenal Activation during Endotoxic 
Shock 
Lutherer et al. (149) showed that acute lesion of the cerebellar fastigial nuclei in 
anesthetized dogs prevented the recovery and maintenance of blood pressure following 
induction of hypotension either by hemorrhage or by administration of endotoxin. This 
implies that the normal sympathetic response to endotoxin challenge requires intact 
central regulatory mechanisms. 
Intact spinal cord also seems critical to endotoxin-evoked sympathetic response. 
Spinal transection at the C-7 level in dogs abolished the catecholamine release in 
response to endotoxin, suggesting that endotoxin-elicited sympathoadrenal response was 
presumably dependent on descending spinal pathways (71). 
Additionally, endotoxin-induced elevation of plasma epinephrine was eliminated by 
section of splanchnic nerves in the dog (176). Fine and associates (253) also 
demonstrated that acute denervation of hemi-spleens protected against the norepinephrine 
depletion whereas the intact spleen was depleted of norepinephrine, typical of the end 
stage of endotoxic shock. This result suggests that increased catecholamine release during 
septic shock depends on nerve activation. 
Recent studies, using more sensitive catecholamine assay, show that peripheral 
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modulation of catecholamine secretion from the adrenal medulla might be present during 
endotoxin shock. In pithed rats with no centrally-mediated reflexes, endotoxin did not 
elevate plasma norepinephrine but epinephrine was still augmented (112), although this 
elevation was greatly attenuated compared to central nervous system (CNS) intact 
animals. These results indicate that norepinephrine release depends on intact CNS while 
epinephrine release may involve both CNS and peripheral (either neurogenic or non-
neurogenic) mechanisms. Evidence of the non-neurogenic stimulation of adrenal 
epinephrine secretion was provided by experiments in newborn rats showing that 
ganglionic blockade could not prevent catecholamine release from the adrenal medulla 
(211). Furthermore, in vitro incubation of adrenal chromaffin cells with endotoxin or 
other endotoxin-elaborated agents enhanced catecholamine secretion (177,225). 
Collectively, only a few studies have been conducted to evaluate central versus 
peripheral involvements in mediating sympathetic activation during sepsis or septic shock. 
The results were not consistent between studies, although it seems that the major 
sympathoadrenal activation during sepsis is dependent on the intact CNS and peripheral 
adrenal modulation may also be present. Further studies are needed to clarify whether 
both central and peripheral mechanisms are involved in this event during septic states. 
Thus, one of the present dissertation projects focuses on examining the central 
dependence of the sympathoadrenal activation during septic shock as well as the 
contribution of peripheral modulation to such activation. 
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c. INVOLVEMENT OF ARTERIAL BARORECEPTORS IN MEDIA TING 
sYMPATHOADRENAL ACTIVATION DURING SEPTIC SHOCK 
I. Baroreceptor Reflex Control of the Circulation 
Reflex regulation of the cardiovascular system is one of the important mechanisms 
in maintaining the homeostasis of the internal environment. Two main types of receptors, 
mechanoreceptors and chemoreceptors, exist in the cardiovascular system and are 
involved in the major reflex control of the circulation. Arterial baroreceptors are the 
mechanoreceptors located in the aortic arch and the carotid sinuses, which monitor 
arterial blood pressure. Afferent sensory fibers from baroreceptors project to the nucleus 
tractus solitarius in the medulla. From there, information is sent to the brain stem nuclei 
which may project directly to the ambiguous nucleus of vagal nerve and the sympathetic 
preganglionic neurons in the intermediolateral column of the spinal cord (220). Studies 
have demonstrated that baroreceptor reflexes can be modified by peripheral as well as 
central mechanisms (47). 
II. Afferent Neural Input from the Arterial Baroreceptors in Mediating Sympathoadrenal 
Activation during Developing Septic Shock 
Since hypotension typically occurs along with increases in heart rate, sympathetic 
nerve discharge and plasma catecholamines during endotoxic shock (93,113,185), it is 
suggested that endotoxin induced-hypotension may be the primary cause of the 
sympathoadrenal activation by unloading baroreceptors and associated deactivation of 
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baroreflexes. In anesthetized dogs and cats, Halinen et al. (92,93) demonstrated that 
endotoxin administration induced a rapid drop of blood pressure which was associated 
with cessation of the aortic arch baroreceptor afferent impulses and increased cardiac 
sympathetic efferent discharges during their 15 min protocol. The author concluded that 
the sympathetic pathways were primarily activated through cardiovascular receptor 
reflexes to maintain blood pressure. Baroreceptor reflex participation in mediating 
sympathetic activation during endotoxic shock has also been suggested by several other 
investigators (159,185). 
However, certain experimental findings in the literature challenge the concept that 
baroreceptor reflexes are the dominant factor in mediating the sympathoadrenal activation 
following endotoxicosis. In rats treated with E. coli bacteria, plasma catecholamines were 
markedly increased while blood pressure was not significantly altered (115). In 
experiments involving bolus administration of endotoxin, plasma catecholamines were 
also markedly enhanced well before hypotension occurred (114). Complete blockade of 
early endotoxin-induced hypotension with platelet activating factor antagonist did not 
prevent catecholamine elevations following endotoxin (196). Direct nerve recording in 
endotoxin and E.coli bacteria treated-animals indicated that sympathetic nerve discharge 
markedly increased with transient decrease in mean blood pressure and remained elevated 
when blood pressure returned to the control levels (185). Mills (159) studied the 
sympathetic response to endotoxicosis in pre-weanling rats before maturation of 
baroreflex and adult rats with matured baroreflex. He reported that sympathetic nerve 
discharge was augmented prior to the onset of hypotension in both groups of rats and 
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additional increases in nerve activity occurred following the fall in blood pressure in 
adults rats but not in pre-weanling rats. The increased activity in both groups persisted 
after blood pressure was restored to basal levels with volume infusion. The author 
concluded that although there was baroreflex participation in the sympathetic activation 
during the hypotensive phase following endotoxicosis, the initiation and continuous 
activation were mediated by non-baroreflexogenic mechanisms. 
Sympathetic activation independent of hypotension was also observed in septic 
patients. Groves et al. (89) reported significantly elevated plasma catecholamines in 
patients with serious postoperative infection. Although some patients in their studies had 
low blood pressures, most were normotensive and none were hypovolemic when plasma 
catecholamines were elevated. They suggest that factors other than the baroreceptor 
reflexes are important causes of increased plasma catecholamines in septic patients. 
Failure to demonstrate a direct relationship between the degree of hypotension and the 
sympathetic activation has been reported elsewhere (96). 
ill. Resetting of Baroreceptor Reflexes during Endotoxin Shock 
The function of the carotid sinus baroreceptors during endotoxemia was investigated 
by Trank and Visscher (238) in pentobarbital anesthetized dogs with cut sinus nerves. 
Endotoxin was shown to produce a left shift of baroreceptor discharge frequency versus 
intrasinus pressure curve. This resetting resulted in post-endotoxin baroreceptor discharge 
frequencies always being higher for a given pressure stimulus compared to control levels. 
The authors speculated that the effect of endotoxin on the carotid sinus baroreceptor 
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activity was not a direct receptor stimulation but an indirect effect produced through a 
chemical mediator released during endotoxicosis. This mediator may sensitize the 
receptors or modify the physical properties of the muscular or elastic components of the 
carotid sinus wall, but the nature of the mediator was not known. 
Recent studies have shown that baroreceptor reflexes can be modulated by certain 
circulating factors. Prostanoids, substance P, atrial natriuretic factor, and vasopressin 
have all been demonstrated to augment the baroreflex control of the circulation 
(35,44,74,249). In other words, at a given carotid sinus pressure those mediators either 
decrease the afferent nerve activity of baroreceptors (peripheral resetting) or increase the 
central efferent sympathetic outflow (central resetting). In contrast, PGI2, opiates, 
endothelial factor, and neurotensin have been linked to the suppression of baroreceptor 
reflexes (48,49,228,256). This suppression was also achieved either by peripheral 
baroreceptor resetting (i.e. increased baroreceptor afferent activity) or by central resetting 
of the coupling between the baroreceptor afferent and nerve efferent activities (i.e. 
decreased central efferent sympathetic activity). These findings may have implications 
in the sympathetic response during septic shock, such that the augmentation of 
baroreceptor reflexes may be involved in reducing sympathetic activity whereas 
suppression of baroreceptor reflex may contribute to enhanced sympathetic outflow. 
As can be summarized from the evidence reviewed in the above two sections (II and 
III), hypotension does not necessarily initiate or maintain the increased sympathoadrenal 
activity which occurs with septic insult despite baroreflex participation for such activation 
during hypotensive state. Modulation of baroreflexes by certain mediators may also 
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influence the sympathetic activation during sepsis, but the nature of such mediator is 
unknown. Regardless of the causes of baroreflex deactivation, the role of baroreceptors 
in mediating sympathetic activation during sepsis/endotoxicosis has never been directly 
evaluated. This will be another focus of the present dissertation studies. 
D. POTENTIAL INVOLVEMENT OF CYTOKINES IN MEDIATING 
SYMPATHOADRENAL ACTIVATION DURING SEPTIC SHOCK 
Cytokines are a family of closely related proteins produced primarily by 
monocytes/macrophages and lymphocytes in response to microbial infection, injury, 
physiological stress, or antigenic challenge (9). Although not released by a specialized 
gland, cytokines, like hormones, can act in autocrine, paracrine, and/or endocrine 
fashions to stimulate their producing cells, local vicinity tissues, or distant sites (65,198). 
Cytokines have a wide range of biological effects on target cells and are responsible for 
mediating a variety of processes in host defense, inflammation, and responses to injury. 
Extensive studies have demonstrated that cytokines are the principal mediators for the 
pathogenesis of endotoxin/septic shock (37,79,174). Particularly, interleukin-1 (IL-1), 
tumor necrosis factor (TNF), and interleukin-6 (IL-6) may be grouped together on the 
basis of related patterns of production and several overlapping activities to mediate 
common effects in the development of septic shock (198). Growing evidence suggests 
that there are interactions between immune and neuroendocrine systems with those 
cytokines as likely mediators. 
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1. Biochemistry of Cytokines 
1. Interleukin- I (IL-1) 
Although activated macrophages are the major source of IL-1, this cytokine is also 
produced by a variety of other cells including fibroblasts, endothelial cells, T and B 
lymphocytes, as well as brain astrocytes and microglial cells etc. (162). IL-1 is initially 
synthesized as a 33,000 dalton precursor, which is subsequently processed during or after 
secretion to molecular weight forms in the range of 13,000-17,000 daltons (86). Two 
distinct genes, IL-1 a and IL-1 {3, have been identified and localized to the long arm of 
chromosome 2. The mature forms of IL-1 a and IL-1 {3 exhibit limited amino acid 
homology (22-26%) and different isoelectric points (pI5 for IL-1 a and pI7 for IL-1 {3) 
(2). In most human tissues IL-1 {3 mRNA predominates over IL-1 a (9). Both molecules 
interact with the same membrane-associated receptors and their biological activities 
appear to be identical (68,198). The human and murine IL-1 {3 or a share approximately 
60-70% homology (198). 
2. Tumor Necrosis Factor (TNF) 
TNF a, also known as cachectin, is a single polypeptide chain of 156-158 amino 
acid residues produced primarily by activated monocytes/macrophages in response to a 
variety of agents including endotoxin, Bacille Calmette Guerin (BCG), and phorbol esters 
(191,233). Natural killer cells, T lymphocytes, astrocytes and some macrophages or 
tumor cell lines can also produce TNF (52,138,192,200,219). TNF is produced as a 
20 
prohormone which undergoes extensive cleavage to generate the mature protein. Studies 
have suggested that human TNF ex exists as a dimer or trimer which dissociates into a 
monomer with molecular weight of 17,000 daltons under denaturing condition ( 4). TNF 
ex is pH and temperature sensitive. The gene for TNF ex has been found on chromosome 
6 in man (217), which is linked to the gene encoding lymphotoxin that is also called TNF 
{3. TNF ex and TNF {3 have a 28 % sequence homology as well as they bind to the same 
receptor and evoke similar biological responses (173). TNF is a highly conserved 
protein, as illustrated by approximately 80% homology between mouse, rabbit and human 
TNF (109,154). 
3. Interleukin-6 (IL-6) 
IL-6 is a glycoprotein with a molecular weight of 23,000-30,000 daltons 
(heterogeneity in size being a function of different glycosylation) (162). The peptide is 
stable at 56 °C but is rapidly inactivated at 100 °C (198). IL-6 can be produced by 
diverse cell types including fibroblasts, monocytes/macrophages, endothelial cells, T and 
B cells, mesangial cells and astrocytes upon appropriate stimulations (162). Those stimuli 
include endotoxin, IL-1, TNF alpha, platelet-derived growth factor and virus infection. 
The human IL-6 gene is located on chromosome 7 (210). About 60 % homology between 
human and mouse has been shown at the DNA level and 42% at the protein level (123). 
II. General Biological Effects of Cytokines 
IL-1, TNF, and IL-6 are the most typical examples of multifunctional cytokines. 
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Their functions are widely overlapping, but each shows its own characteristic properties. 
IL-1 was originally discovered as an endogenous pyrogen which induced fever 
(198). IL-1 has a broad spectrum of target cells that share a common involvement in 
immune or inflammatory responses. For example, IL-1 aids in the development of 
specific immune responses by regulating the activation of T and B cells and by 
stimulating the release of growth and differentiation factors that act on T and B cells 
(5,63,174). IL-1 has proinflammatory effects on a variety of cells including fibroblasts, 
synoviale cells, chondrocytes, endothelial cells, hepatocytes, and osteoclasts (63,162). 
IL-1 also increases the hepatic acute phase protein synthesis and mediates many other 
metabolic alterations (64, 78). A key feature of IL-1 action is to stimulate the arachidonic 
acid metabolism which may be involved in many responses in different organs or 
systems such as cardiovascular, pulmonary, and neuroendocrine systems (63,140,198). 
TNF was first identified as an endotoxin-induced factor causing hemorrhagic 
necrosis in certain tumors in vivo (42). It is now evident that both TNF a and fJ possess 
cytolytic and cytostatic properties for certain solid tumors in vivo and specific tumor lines 
in vitro (9). TNF a appears to play a major role in trapping neutrophils in a localized 
inflammatory area by increasing the expression of adhesion molecules on the surface of 
both endothelial cells and neutrophils (36,124). TNF a could further stimulate neutrophil 
phagocytosis and superoxide anion production as well as be involved in driving the 
anticoagulant status of the endothelium to a procoagulant state (124). TNF a can also 
induce some cells such as endothelial cells and fibroblasts to secrete a number of 
important immune mediators (198). These mediators, including IL-1, platelet-activating 
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factor, prostaglandins, interferons, colony-stimulating factor (CSF) and collagenase, may 
actively participate in local and systemic immune responses. TNF 0t has been 
demonstrated to induce the differentiation and proliferation of B lymphocytes (110). TNF 
a also has endogenous properties to cause fever (66) and is involved in acute phase 
response (24). Suppression of lipoprotein lipase production may be one of the 
mechanisms for cachexia associated with TNF (163). 
IL-6 was initially described as T cell derived-lymphokine that induced antibody 
production in B cells (123). IL-6 can markedly influence the growth and differentiation 
of T and B lymphocytes, especially in the presence of other stimuli such as IL-1 (5). IL-6 
can also stimulate the growth of hematopoietic colonies composed of granulocytes and 
macrophage and modify the effects of other hematopoietic factors (123). Nerve-growth 
factor-like activity of IL-6 has been suggested. IL-6 can act as a pyrogen (100) and is 
involved in mediating the acute phase responses by liver cells (83). 
A cytokine network exists, as indicated by the induction of these cytokines (5). For 
example, TNF induces IL-1 expression and vice versa. IL-1 and TNF both induce IL-6. 
Unlike IL-1 and TNF, IL-6 does not induce IL-1 or TNF. IL-6 suppresses endotoxin- or 
TNF-induced IL-1 production as well as endotoxin-induced TNF production. Moreover, 
IL-1, IL-6 and TNF are each capable of inducing their own production. Thus, this 
network implies complex functional links between those cytokines. 
III. Involvement of Cytokines in the Pathogenesis of Septic/Endotoxin Shock 
The involvement of IL-1, TNF and IL-6 as key mediators in the pathogenesis of 
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septic/endotoxic shock are mainly demonstrated by three separate lines of evidence. First, 
a marked elevation of production and secretion of each of the cytokines have been 
demonstrated during the development of septic/endotoxin shock. Second, administration 
of exogenous cytokines can duplicate most of the manifestations and pathophysiological 
changes associated with septic/endotoxic shock. Third, treatment of the septic animals 
with specific antibodies against those cytokines shows protective effects and decreases 
lethality. 
1. Circulating Cytokines Levels in Septic Patients and Animal Models 
Several investigators have demonstrated that in septic patients, there are elevations 
of plasma TNF levels, either alone or along with increased IL-1 or IL-6 
(41,57,60,178,245). High level of TNF or IL-6 has been associated with severity and 
high mortality in some studies (178,245). Michie et al. (158) reported that endotoxin 
administration (4 ng/kg) to healthy human volunteers induced a 7 fold single peak 
elevation of plasma TNF levels within 90 -180 min while IL-1 level did not change. 
However, detectable elevations of IL-1 at 120 min and IL-6 at 2 to 4 hr following 
endotoxin in human volunteers have been demonstrated in other studies (80,101). 
Increases in circulating TNF, IL-1, and IL-6 have been substantiated in septic 
models with endotoxin or bacterial injections in different animal species 
(73,81,121,155,244). Mathison et al. (155) reported that elevation of plasma TNF was 
detected within 30 min and peaked between 45 to 120 min after endotoxin challenge in 
rabbits. In studies with baboons, Fong et al. (81) demonstrated that circulating TNF was 
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increased with peak elevation at 1.5 hr after E. coli injection. IL-1 was detectable by 2 
hr and peaked 3 hr after bacterial infusion. IL-6 was detectable within 3 hr and continued 
to rise throughout 8 hrs of the protocol. 
2. Duplication of Septic Syndromes by Cytokine Administration 
Extensive studies have shown that TNF administration in different animal models 
precipitates a syndrome strikingly similar to that of human septic shock (18,53,234,236). 
Tracey et al. (234) reported that recombinant human TNF infusion induced dose-related 
endotoxin-like syndrome, tissue injury, and death. Endotoxic shock-like syndrome was 
also observed in TNF-treated rats, including hypotension, tachycardia, hyperglycemia, 
lactacidemia, hemoconcentration. Pathological analysis revealed organ-specific changes 
indistinguishable from those seen during human septic shock such as adrenal necrosis, 
pulmonary inflammation and hemorrhage. Cardiovascular collapse along with tissue 
necrosis and elevation of stress hormones was also observed in canine models after TNF 
infusion (236). The modulation effects of TNF on endotoxin-induced hemodynamic, 
metabolic and endocrine responses have been demonstrated (53). 
Relatively few studies have examined the pathophysiological alterations associated 
with IL-1 administration. Okusawa et al. (179) reported that intravenous treatment of IL-
I /3 (5 mg/kg) to rabbits induced hypotension, decreased vascular resistance and 
decreased central venous pressure. In studies with mice, Beutler et al. (40) demonstrated 
that IL-1 ex and (3 induced dose-dependent lethality and pathological changes similar to 
septic shock. Using nontoxic doses of IL-1 (3 and TNF in combination in rabbits, a 
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profound shock-like state was induced with evidence of pulmonary edema and 
hemorrhage (179). It is suggested that the combination of IL-1 and TNF together is much 
more potent than either agent alone. 
3. Protective Effects of Cytokine Antibodies 
Using polyclonal rabbit antiserum and the derived IgG against TNF to passively 
immunize mice, Beutler et al. (25) reported that endotoxin induced lethal effects were 
significantly attenuated in a dose-dependent manner. The protective effects were most 
effective when antiserum was given prior to endotoxin injection. Tracy et al. (235) 
reported that pretreatment of baboons with monoclonal anti-TNF antibody fragments 
(Fab2) 2 hr before LD 100 of E. coli bacteria infusion provided complete protection 
against shock, vital organ dysfunction, and persistent stress hormone release. Anti-TNF 
antibodies also attenuated the E. coli bacteria-induced elevation of TNF, IL-1 /3 and IL-6 
(81), suggesting that TNF may be essential for the initiation and amplification of IL-1 
and IL-6 release during septic shock. 
Wallach et al. (246) demonstrated that treatment with IL-1 (0.4 µg, ip) 12 hr before 
endotoxin injection (100 µg, iv) to BCG-primed mice prevented the lethal effects of 
endotoxin, suggesting that IL-1 was an important mediator in endotoxin lethal effects. 
In recent studies by Starnes et al. (221) the effects of in vivo anti-mouse IL-6 
antibody treatment were evaluated in a mouse model of septic shock. Anti-IL-6 
antibodies significantly attenuated the lethality caused by E. coli (ip) or murine 
recombinant TNF a, suggesting that IL-6 is an important mediator in lethal E. coli 
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infection. Anti-IL-6 also led to an increase in E. coli induced elevation of serum TNF 
levels, implicating that IL-6 was a negative modulator of TNF in vivo. 
Clearly, extensive studies have demonstrated that TNF, IL-1 and IL-6 are the 
principle mediators in the pathogenesis of sepsis and septic shock. More exhaustive 
review of this topic can be found in a recent monograph (79). 
IV. Centrally-Mediated Effects of Cytokines 
1. Fever 
Fever is well known to be a centrally-regulated response. The temperature regulation 
center is primarily located in the anterior hypothalamus (10). When endotoxin, the 
exogenous pyrogen was administered intravenously (i. v .) to rabbits, it caused monophasic 
fever at small doses but biphasic fever at larger doses (164). It is now recognized that 
the exogenous pyrogens exert their pyrogenic effects by releasing several endogenous 
pyrogens such as TNF a, IL-1, and IL-6. These systemically released cytokines are 
presumably transported to the brain by the blood and initiate fever by increasing 
prostaglandin PGE2 synthesis in the hypothalamus. It is not known how the cytokine 
signals in the circulation get into the hypothalamus (26,222). 
Intravenous injection of human recombinant IL-1 into rabbits resulted in a 
monophasic fever which peaked approximately 50 min after injection (66). This fever 
induction was more rapid than endotoxin-induced fever which peaked approximately 90 
min post administration. TNF a is also pyrogenic and has dose-dependent fever-inducing 
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properties. Small i. v. dose of TNF induced a brisk, monophasic fever which peaked 
coincidentally with IL-I induced fever (66). High doses of TNF a resulted in a biphasic 
fever profile. The initial peak, which was corespondent to the monophasic peak observed 
with small dose of TNF, was followed by a second peak at 3.5 hr post injection. 
Pretreatment with a cyclooxygenase inhibitor could block IL-1 induced fever as well as 
the initial rise in temperature evoked by TNF. The second peak has been demonstrated 
to be mediated by TNF-induced IL-1 release (66,243). Intravenous injection of IL-6 to 
rabbits also produced fever response which was monophasic with peak elevation around 
60 min (100). 
2. Neuro-Endocrine System 
Extensive studies have been conducted to investigate the cytokine effects on the 
neuro-endocrine systems, particularly the hypothalamus-pituitary-adrenal axis. 
IL-1 has been reported to increase serum levels of adrenocorticotrophic hormone 
(ACTH) and corticosterone in different species (22,182). Such elevations are primarily 
mediated through central mechanisms. Intracerebroventricular (ICV) administration of 
IL-I-stimulated secretion of ACTH and corticosterone, whereas the same dose was not 
effective when injected peripherally (119,182). It has been shown that IL-1 stimulates 
ACTH and subsequent corticosterone secretion by triggering release of corticotropin-
releasing factor (CRF) from the hypothalamus, as measured from both systemic (22) and 
hypothalamic-pituitary portal circulations (206). Pretreatment with CRF antibodies 
abolished the IL-I-induced increase in ACTH (206). Complete neural dissociation of the 
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medial basal hypothalamus prevented the adrenocortical activation produced by IL-1 
(182). Additional effects of IL-1 at the level of the pituitary and the adrenal gland has 
also been proposed ( 16). 
Similarly, TNF as well as IL-6 have also been demonstrated to stimulate the 
hypothalamic-pituitary-adrenal axis (53,59,72,170,213,236,247). In vitro incubation of 
the pituitary with IL-6 induced ACTH secretion (150). Intravenous administration ofIL-6 
into rats increased the plasma level of ACTH 30 min after the injection (170). 
Pretreatment with anti-CRF completely abolished the IL-6 induced increase of ACTH 
(170), suggesting that IL-6 stimulated the secretion of ACTH through CRF. 
Recent evidence indicates that IL-1 and TNF modulate the secretion of various other 
hypothalamic-pituitary peptides, including prolactin, growth hormone, thyrotropin-
releasing hormone, and luteinizing hormone-releasing hormone (26,199). 
3. Sympathetic Nervous System 
Cytokine-induced activation of the sympathetic nervous system has been reported 
by several authors. In 1987, Tracey et al. (236) investigated the stress hormone responses 
to recombinant human TNF in anesthetized dogs. Intra-arterial infusion of sublethal dose 
of TNF (10 µg/kg) induced no significant changes in plasma catecholamines. Lethal dose 
of TNF (100 µg/kg), however, precipitated significant increases of plasma 
catecholamines. Within 15 min after TNF infusion, plasma epinephrine and 
norepinephrine increased from a pre-injection value of 58 and 282 pg/ml to 1148 and 
1400 pg/ml, respectively. By 3 hrs, plasma epinephrine and norepinephrine were elevated 
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to 1623 and 1982 pg/ml, respectively. Since these elevations occurred prior to the onset 
of diminished mean blood pressure or cardiac output, the authors proposed that 
circulating TNF may stimulate the sympathetic response. Sharp et al. (213) showed that 
ICV injection of TNF was more effective than intravenous (iv) injection, which may 
suggest a central site of action for TNF. 
In 1988 Bagby et al.(11) demonstrated that non-lethal dose of TNF (150 µg/kg, iv) 
induced about 2-3 fold increase in plasma epinephrine and norepinephrine in conscious 
rats, which was not associated with hypotension. Similar findings were also observed by 
Darling et al. (59), except that the increment of epinephrine did not reach statistical 
significance. In recent studies with conscious rats, Ciancio et al. (53) reported that 
significant elevation in plasma catecholamine were induced within 90 min after high dose 
of TNF injection (1 mg/kg), with peak elevation of approximately 20 fold. 
In anesthetized dogs Evans et al. (72) reported that 6-hr infusion of sublethal dose 
of TNF increased stress hormone levels including plasma catecholamines, which were 
associated with hemodynamic and metabolic changes. Pretreatment with cyclooxygenase 
inhibitors abolished most of the hemodynamic changes and attenuated elevation of plasma 
catecholamines. In contrast to the plasma catecholamine response to TNF, Holt et al. 
(106) reported that ICV injection of TNF ex resulted in decreased sympathetic firing rate 
to interscapular adipose tissue, whereas lymphotoxin (TNF {3) increased the sympathetic 
nerve activity to that tissue. The authors proposed that both cytokines acted directly in 
the CNS to modulate sympathetic outflow, possibly via separate receptor systems. 
Recombinant IL-1 ex and IL-1 {3 have also been evaluated for their ability to 
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stimulate catecholamine secretion in the rat (202). Intravenous injection of either IL-1 a 
or IL-1 {3 (1-1000 ng) caused dose-related but modest increases in plasma catecholamines 
at 15 min post injection. Similarly, ICY administration of same doses of IL-1 induced 
2-3 fold elevation of plasma catecholamines. In both cases no alteration in blood pressure 
occurred, suggesting that this elevation does not result from a cardiovascular reflex. 
A recent study assessed norepinephrine turnover in various organs of rats after 
intraperitoneal injection of recombinant human IL-1 {3 (6). IL-1 administration increased 
norepinephrine turnover in the spleen, lung and hypothalamus. Modest elevation of 
plasma catecholamine levels was also observed 30 min and 1 hr following intraperitoneal 
IL-1 injection (21). 
Saigusa (204) studied the regional sympathetic response to IL-1 {3 and TNF a using 
anesthetized rabbits. He found that each of the cytokines typically induced a decrease in 
ear temperature, indicative of cutaneous sympathetic activation, and simultaneous 
inhibition of renal sympathetic nerve activity at the initial phase (30 min) which returned 
to control levels around 60 min post treatment. 
4. Others 
In addition to the above-mentioned central effects of cytokines, IL-1 and TNF have 
also been shown to induce many other centrally-mediated host defense responses to 
infectious pathogens. Among those are acute-phase glycoproteinemia (214), 
hyperinsulinemia (55), increased counts of white blood cells, enhanced slow-wave sleep 
(30) and suppression of food intake (194). 
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v. Passages of Cytokines To the Brain 
A prerequisite for a direct CNS effects of systemic endotoxin or cytokines is that 
the specific molecule contacts CNS elements. Controversial results have been reported 
in the literature regarding the possibility of systemic endotoxin and cytokines entering the 
CNS and interacting with the brain parenchyma. 
Prior to the understanding of cytokines, endotoxin was believed to be the causative 
factor for the pathogenesis of gram-negative septic shock. At that time, some evidence 
suggested direct actions of endotoxin on the CNS which might be responsible for some 
of its effects. Experiments were then onducted attempting to establish the basis of direct 
contact of endotoxin with CNS components. Bennett et al. (20) presented evidence that 
endotoxin was found in cerebrospinal fluid (CSF) of dogs within 15-30 min after 
intravenous injection of Shigella endotoxin, using the pyrogenic effects in rabbits as an 
assay. In contrast, most other studies reported negative results in general. When 
radioactive-labelled endotoxin was given systemically, no endotoxin was found in the 
brain parenchyma although radioactivity was detected throughout peripheral organs ( 109). 
In another experiment involving intravenous endotoxin administration, no endotoxin was 
detected in the CSF during the period when plasma endotoxin was at its highest 
concentration (240). Although in a few cases of this experiment, a low level of endotoxin 
was found in the CSF, it was usually correlated with high red blood cell count in the 
CSF, and it was considered to be due to contamination from cerebral bleeding during the 
CSF sampling. From these studies, the generally accepted view is that endotoxin cannot 
cross the blood brain barrier. 
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It is now recognized that host-released factors, primarily cytokines, are responsible 
for most of endotoxin effects, including those involved in the CNS. However, whether 
cytokines have direct physical contact with the brain tissues is not clear. Experiments in 
the past several years have focused on three major aspects: 1) whether cytokines can 
cross the blood brain barrier, 2) whether circulating cytokines enter the brain at the 
circumventricular organs where the blood brain barrier is absent, and 3) whether 
cytokines are produced locally in the brain and, thereby, exert their actions. 
In 1987 Dinarello et al. (67) reported that intravenous injection of 125I labelled 
endogenous pyrogen (EP), prepared from monocytes, did not induce any radioactive 
detection in the anterior hypothalamus. In 1987 the same group (54) reported that when 
endotoxin or IL-1 was given intravenously, CSF IL-1 concentration did not increase at 
any stages of the sustained fever, suggesting that IL-1 did not cross the blood brain 
barrier. In contrast, when pyrogenic doses of endotoxin or IL-1 (3 was administered ICY, 
elevation of IL-1 in the CSF was detected, indicating the ability of brain tissues to 
produce IL-1 in vivo. Bank et al. (12) reported bidirectional transports of IL-1 a across 
the blood brain barrier. In their studies 125I-radiolabled IL-1 a, which retains full 
biological activity, was injected intravenously into mice along with 99J'e-radiolabled 
albumin. When the brain/serum radioactivity ratio was counted at different times post 
injection, the ratio for 125I increased significantly over time whereas the ratio for 99J'e 
stayed constant, suggesting that there was a blood to brain transport of IL-1 but not 
albumin. Many regions of the brain contained IL-1 radioactivity. The brain to blood 
transport of IL-1 was also demonstrated in the same studies. 
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In another line of investigation, the possible role of organum vasculosum laminae 
terminalis (OVLT) in connection with the pathogenesis of fever and activation of 
hypothalamic-pituitary-adrenal axis was extensively studied. OVLT is one of the seven 
or eight so called "circumventricular organs"as it is adjacent to the cerebral ventricles. 
The OVLT is highly vascularized and lacks a blood brain barrier (111). Some big 
molecules such as horseradish peroxidase (HRP) (45,00 dalton) can not cross the blood 
brain barrier but can reach interstitial space of the OVLT (222). The ependyma of the 
OVLT faces toward the third ventricle and the parenchyma of the OVLT is comprised 
of neuronal perikarya, glial and neuronal processes. The OVLT is close to the 
hypothalamus and has direct projections to the hypothalamus which is known to be an 
important area in autonomic, endocrine and fever regulations (111). 
In studies with guinea pigs, Blatteis reported that an extensive lesion of the 
anteroventral third ventricular wall including OVLT resulted in suppression of the febrile 
response evoked by systemically administered endotoxin, IL-1 and TNF (27-29). Direct 
injection of endogenous pyrogen into the preoptic region of the hypothalamus in the 
lesioned rats, however, induced fever similar to that seen in sham rats (27). They 
proposed that the OVLT may be the passage site of systemic endogenous pyrogens to the 
preoptic region of the hypothalamus which directly responds to pyrogens to induce fever. 
Thus, lesions of the OVLT subsequently prevent the entry of pyrogens into the brain. 
In contrast, Stitt et al. (222) reported different findings. Small perhaps incomplete 
lesion of the OVLT region in rabbits greatly augmented the febrile response to 
endogenous pyrogen with maximum responses 3-6 days post lesions which gradually 
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diminished over 3-4 weeks. They suggested that this enhanced response may be due to 
increased phagocytosis in the remaining OVLT cells since zymosan, a phagocytotic 
stimulating agent, produced similar enhancement of the febrile response. Similarly, 
Katsuura et al. (116) demonstrated that OVLT lesion enhanced the intravenous IL-1 {3-
induced ACTH response whereas lesions of preoptic area of the hypothalamus suppressed 
the response. They proposed that the OVLT may be the entry site of blood-borne IL-1 
p into the brain leading to the preoptic area of the hypothalamus, which may contain the 
neurons required for the ACTH response. 
Finally, using antiserum directed against human IL-1 /j to stain the human brain 
immunohistologically (34), IL-1 /j immunoreactive fibers were found in many areas of 
the brain with a heavy innervation to the hypothalamus. Similarly, immunoreactive IL-1 
/j also present in the hypothalamus and the extrahypothalamic regions of the rat brain 
(136). The authors speculated that IL-1 may be an intrinsic neuromodulator in the central 
pathways that may mediate neuroendocrine, febrile and many other responses. In vitro 
production of IL-1, IL-6 and TNF by certain brain cells such as astrocytes and glial cells 
in response to endotoxin challenge or viral infection have also been demonstrated 
(138,200,215). Furthermore, in vivo production of those three cytokines in the brain or 
CSF has also been demonstrated in a variety of infectious or inflammatory states 
(82,95,105,135). For example, Fontana et al. (82) studied the in vivo synthesis of IL-
i/endogenous pyrogen within the brain of endotoxin treated mice. They found that IL-1 
activity of brain extract, as determined by stimulating phytohemagglutinin (PHA)-initiated 
proliferation of thymocytes, increased in a dose-dependent manner 5 hr after the injection 
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of 50 µg endotoxin (i.p.). The enhanced IL-1 activity was first detectable 3 hr post 
endotoxin. The febrile response induced by the brain extract was in accord with 
temperature changes observed in purified IL-1 treated mice. A recent study by 
Hallenbeck et al. (95) showed that the ICV injection of endotoxin (at doses of 1.8 and 
3.6 mg/kg) induced a dose-dependent TNF production, as detected in the CSF. Elevated 
mRNA expressions of IL-1, IL-6, and/or TNF in the rat brain particularly the 
hypothalamus have also been observed in vivo following the central administration of 
gamma-interferon and endotoxin, systemic injection of kainic acid, and immobilization 
stress (102,160,161). Immobilization induced IL-1 mRNA was detected as early as 30 
min after the start of the stress and reached a maximum at 60 min (161). 
VI. Evidence for the Hypothalamus as the Potential Action Sites of Cytokines in the 
Brain 
Several authors have reported changes, either increases or decreases, in the 
electrophysiological activity of hypothalamic neurons during the immune response 
(23,205,216). Electrophoretically applied recombinant human IL-1 {3 (rhIL-1{3) and 
rhTNF have also been shown to suppress the activity of glucose-sensitive neurons in the 
rat lateral hypothalamic area and increase the neuronal activity of glucoreceptor neurons 
in the rat ventromedial hypothalamic nucleus (180,194). Hypothalamic neurons could be 
excited by interleukin-I in vitro (107). Enhanced hypothalamic norepinephrine 
metabolism following the IL-1 treatment, either in vivo or in vitro, has also been 
demonstrated (69,183,184,248). Direct injection of cytokines to different areas of the 
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hYPothalamus induces a febrile response (27), hyperinsulinemia (55) and suppression of 
food intake (194). In vitro incubation of the hypothalamus with either IL-1 or IL-6 
stimulated CRF secretion (172,241). Therefore, the hypothalamus has been considered 
to be one of the most important sites for cytokine actions. 
As can be summarized from the cytokine review, many host defense responses to 
infectious and inflammatory processes are mediated by cytokines via their central actions. 
Some of the cytokine effects may be initiated in the brain side of the blood brain barrier, 
particularly the hypothalamus. Relevant to the interest of the present dissertation study, 
cytokines may act in the CNS, possibly the hypothalamus, to mediate the 
sympathoadrenal activation during developing septic shock. However, these possibilities 
have not been examined in a systematic manner, which will be the focus of another 
project of the dissertation study. 
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THE RATIONALE 
Despite extensive demonstrations of the sympathoadrenal activation during 
developing septic shock, mechanisms responsible for this activation are apparently 
unknown and basically unexplored. After review of the limited and indirect data in the 
literature, three themes might be suggested. First, major sympathoadrenal activation in 
response to endotoxin challenge may be dependent on an intact CNS. Peripheral 
modulation of epinephrine release from the adrenal gland might also make minor 
contribution to the overall sympathoadrenal activation during endotoxicosis. Second, 
afferent neural input from arterial baroreceptors may not have a dominant role in 
mediating the sympathoadrenal activation in endotoxin shock. Third, interactions between 
the immune-neuroendocrine systems exist with cytokines as likely mediators. This 
interaction may also be applicable to the sympathetic response to endotoxic challenge 
such that cytokines may mediate the sympathoadrenal activation during septic shock via 
their central actions. However, these three aspects have never been studied directly, or 
in a systematic manner. Thus, the presently proposed dissertation study will focus on 
these potential mechanisms of sympathoadrenal activation in endotoxin shock. The 
specific aims include: 1) to examine the overall contributions of central nervous system 
as well as peripheral modulation (either neurogenic or non-neurogenic) to the 
sympathoadrenal response in endotoxin shock, 2) to evaluate the role of afferent neural 
input from the arterial baroreceptors in mediating sympathoadrenal activation during 
endotoxic shock, and 3) to assess the central roles of three major cytokines, IL-1, IL-6 
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and TNF, as mediators of the sympathoadrenal activation. 
CHAPTER III 
GENERAL MATERIALS AND METHODS 
A. ANIMALS 
Male, Holtzman rats, obtained from Harlan Sprague Dawley Inc. (Indianapolis), 
weighing 300-500 g, were used in all experiments. The rats were housed in shoe box 
cages with filter tops at least 1 week before use in order to recover from the stress of 
shipping and to adjust to the new environment. Ambient temperature was approximately 
22 °C to 25°C, and the illumination was controlled on 12 hr light-dark cycle. Wayne Lab. 
Blox (full nutrient meal) and tap water were provided ad libitum except where indicated 
prior to some experimental protocols. 
B. CARDIOVASCULAR INSTRUMENTATION AND MEASUREMENTS 
Arterial and venous cannulae were implanted either on the day of experiments for 
acute preparations or the day prior to experiments for chronic preparations. These 
cannulae permitted monitoring the hemodynamic changes (e.g. arterial blood pressure, 
heart rate), collecting blood samples, or administering intravenous drugs throughout the 
time course of experiments. In experiments with sinoaortic baroreceptor denervation, 
femoral vessels rather than carotid arteries were cannulated to avoid any potential 
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disturbances in the carotid sinus regions. In all other studies, carotid artery and jugular 
vein cannulae were used. 
For femoral vessel cannulation, a 1 cm long incision was made in the left inguinal 
area. After exposure of the femoral vessels by blunt dissection, the arterial and venous 
cannulae (PE-50 polyethylene tubing, Clay-Adams, NY), filled with heparinized saline 
(100 U/ml), were inserted approximately 5 cm to the level of abdominal aorta and 
inferior vena cava, respectively. 
For carotid artery and jugular vein cannulation, a 2 cm ventral midline incision was 
made in the neck and blunt dissection was employed to expose the vessels. The arterial 
and venous cannulae were advanced approximately 3 cm to the level of the ascending 
aorta and superior vena cava-right atrial junction, respectively. 
In conscious rat experiments the ends of the cannulae were heat sealed, tunneled 
under the skin, and were exteriorized through the back of the neck in the interscapular 
region. The cannulated animals were then placed one per cage to prevent damage to the 
cannulae and fasted for about 24 hrs with free access to water. 
Prior to the onset of experimentation, the arterial cannula was extended to a saline-
filled Statham pressure transducer (model P23) via a tygon tubing adaptor and additional 
PE-50 tubing. Pulsatile as well as mean blood pressures (MBP) were monitored 
continuously using a Grass oscillograph (model 7). The heart rate (HR) was determined 
from the pressure pulses. Extension of the venous line provided a convenient means for 
intravenous drug administration and replacing volume for blood sampling. Care was 
taken to minimize heparin administration to each rat during experiments by withdrawing 
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the heparinized saline before flushing the cannula with non-heparinized saline. Before 
beginning each experiment, rats were allowed time (approximately 30 min) to become 
acclimatized to their environment as determined by normal, steady mean arterial blood 
pressures (approximately 90-120 mmHg) and heart rates (approximately 300-400 
beats/min) as well as by quiet behavior. 
c. Sinoaortic Baroreceptor Denervation 
Sinoaortic baroreceptor denervation (SAD) was performed by a modification of the 
method originally described by Krieger (133). Anesthetized animals were placed in a 
supine position on a warm pad. Using aseptic technique, a midline incision (2.5-3 cm) 
was made in the neck and the neurovascular sheath enclosing the common carotid 
arteries, the vagi, and the cervical sympathetic nerve trunks were exposed by retracting 
the sternohyoid and sternomastoid muscles. The vagi were carefully separated from the 
neurovascular sheath with the aid of a dissecting microscope (0. 7x-3x, Bausch & Lomb 
Inc.). For aortic baroreceptor denervation, the superior laryngeal nerves were cut near 
the vagi and the superior cervical ganglia including a small segment of the sympathetic 
chain were removed to prevent the possibility of reconnection. Aortic depressor nerves, 
usually found associated with the sympathetic trunk, were sectioned when evident. For 
carotid sinus denervation, the area of the carotid bifurcation was widely exposed. All 
connective tissue and nerve fibers were stripped from the thyroid, occipital, internal, 
external and common carotid arteries. Extra care was taken to prevent injury of vagal 
nerves. Sham operations were performed by exposing the carotid sinuses bilaterally 
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without dissection of the region. Bilateral sinoaortic denervation was normally performed 
in a one-stage operation lasting approximately 30 min. In chronic SAD and sham 
preparations, animals received 40,000 IU penicillin (i.m.) following the surgery and were 
allowed 2-4 weeks for recovery. 
Completeness of the baroreceptor denervation was tested by determining the 
magnitude of the reflex bradycardia in response to phenylephrine-induced hypertension 
( 4 µglkg, i. v.) and the reflex tachycardia in response to nitroglycerine-induced 
hypotension (0.5 µglkg, i.v.). Such observations have been routinely used as the criteria 
of the effectiveness of the SAD (8,13,169,239). Only those animals which exhibited a 
reflex bradycardia of < 20 beats/minute and a reflex tachycardia of < 20 beats/minute 
in response to 40-50 mmHg change in MBP were accepted as SAD rats (8). The 
bradycardia or tachycardia typically observed in sham controls was 60-120 beats/min 
after the same dose of phenylephrine or nitroglycerine. 
D. SYMPATHETIC NERVE RECORDINGS 
Renal sympathetic nerve activity (RSNA) was recorded from a renal branch of the 
left greater splanchnic nerve (61,185). Using aseptic techniques, the left kidney was 
exposed retroperitoneally through a flank incision. The renal nerve branch was usually 
found in the aortic-renal artery angle, coursing to the renal vascular pedicle through the 
perirenal fat and into the hilus of the kidney. Under a dissection microscope, the renal 
nerve was gently separated from fat and connective tissues, and carefully placed on a 
thin, bipolar gold electrode hook. The gold electrodes were teflon-coated with one end 
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bared, bent to a hook, and the other end connected to extension cables. When an optimal 
nerve signal was obtained, the electrode and the nerve were fixed with a mixture of equal 
parts of dental elastomeric impression material base, catalyst (both from Sybron-Kerr, 
Romulus, MI), and RTV silicon gel base (Petrarch Systems Inc., Bristol, PA). After 
closure of the incision in layers, the electrode cables were tunnelled subcutaneously and 
exteriorized on the back of the neck. 
On the next day, the electrode cables were extended to an amplifier while the 
conscious rats were in cages. The nerve signal was amplified 1,000-10,000 fold and 
filtered (low-frequency cutoff at 35 Hz and high-frequency cutoff at 2,000 Hz) by a 
Grass model HIP511A pre-amplifier and a Grass model P511R amplifier. The amplified 
signal was continuously displayed on an oscilloscope (Tektronix Inc., Type 561A) and 
led to an audio amplifier/loud speaker (Grass AM?). Representative oscilloscope displays 
of amplified raw renal sympathetic nerve activity from unrestrained, conscious rats are 
shown in figure 3-1. For estimation of frequencies of RSNA, the signal was full-wave 
rectified and integrated by a Grass model 7P3A integrator with a time constant 0.02 sec 
and the spikes/min were measured. For simultaneous estimation of overall RSNA, which 
involves both frequencies of RSNA and amplitudes of RSNA spikes, the amplified signal 
was also rectified and integrated by a Grass model 7P10E integrator and the slopes of 
integration were determined. In both cases, the rectified-integrated signal was 
continuously recorded using a Grass oscillograph (model 7). 
The background noise level for the nerve recording was determined 30 min after 
each animal was euthanized with i. v. pentobarbital overdose. For RSNA spike 
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- 50 msec/division 
Figure 3-1.0scilloscope display of amplified raw renal sympathetic nerve activity from 
unrestrained, conscious rats. 
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measurement, only spikes with amplitudes greater than background noise level were 
counted. For slope measurement, background noise slope was subtracted from the mean 
rectified nerve signal slope obtained in the living animal. All RSNA were sampled for 
20 sec at indicated sampling times and expressed as percent change from baseline 
control. Percent changes of RSNA were used because the absolute value of multiunit 
activity is influenced by recording conditions that vary between different preparations. 
Such variations include the spatial relationship of the nerve fibers to the electrodes and 
the amount of tissue fluid around each nerve. 
E. IMPLANTATION OF INTRACEREBROVENTRICULAR (ICV) CANNULA 
Anesthetized rats were placed in a stereotaxic apparatus (Trent H. Wells Jr. 
Mechanical Developments Co. South Gate, CA) in a prone position. A 2 cm midline 
incision was made on the skull and the bregma was exposed. After determining the 
coordinates for the right lateral ventricle using the bregma as a reference point, a small 
hole (0.5 mm diameter) was made with an electric drill. A 30 gauge stainless steel 
cannula was inserted through the hole in the skull into the lateral ventricle with the tip 
coordinates: 0.5 mm caudal to bregma, 1.5 mm lateral to the midline, and 4.5 mm below 
the surface of the skull (10). The end of the cannula was pre-bent to a right angle and 
connected to a piece of PE-10 tubing (5 cm long), filled with saline (3-4 µl) and heat 
sealed. Two stainless steel anchoring screws were fixed on the skull, and the cannula 
secured in place by dental acrylic cement. The incision was sutured with the end of the 
PE-10 tubing exteriorized. On the day of experiment, the cannula was connected to a 10 
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µI Hamilton microsyringe filled with test solution. A 10 µl test solution (plus 3-4 µl 
saline in the cannula) was infused over a period of 5 min. 
At the end of each experiment, methylene blue dye solution (15 µl) was injected via 
the cannula. The animals were sacrificed with pentobarbital overdose (i.v.), and the 
brains were removed. The exact location of the injection was verified. Only those 
animals with successful ICV injections, as indicated by staining of the lateral ventricles, 
were included in the data analysis. 
F. IMPLANTATION OF CANNULAE INTO THE PARA VENTRICULAR NUCLEUS 
OF THE HYPOTHALAMUS (PVN) 
Cannulae for injections into the paraventricular nucleus of the hypothalamus (PVN) 
were implanted using a stereotaxic apparatus. After exposure of the bregma under 
anesthesia, a 3 mm x 1 mm slot was prepared across the midsagittal suture on the skull 
with a electric drill. A bilateral guide cannula (Plastic One Inc., Roanoke, VA), 
constructed of two 26-gauge stainless steel tubes with a 1. 0 mm distance between the 
centers, was implanted in the bilateral PVN through the slot in the skull. The coordinates 
for this position were: 1. 7 mm caudal to the bregma, 0.5 mm lateral to the midsagital 
suture, and 8.0 mm ventral to the skull surface with the incisor bar set at 4.0 mm below 
the interaural line (190). Four stainless steel anchoring screws were fixed on the skull, 
and the cannula secured in place with dental acrylic cement. The incision was closed with 
a suture. A dummy wire with two leads was inserted into the guide cannula to prevent 
clotting in the cannula and also prevent dust from getting into the cannula. On the day 
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of experiments, the dummy wires were removed and a double injector cannula (33 gauge, 
Plastic One Inc.), which was 2 mm longer than the guide cannula, was inserted into the 
guide cannula. The injector cannula, filled with test solution, was connected to a 10 µI 
Hamilton microsyringe via a flexible tygon tubing (same size as PE-10, Norton Tubing 
and Molded Products, Akron, OH). Testing solution (500 nl) was injected bilaterally over 
a 5 min period. The volume of an injection was monitored by observing the movement 
of a small bubble through a calibrated distance in the tubing. 
For histological verification of the injection site, pentobarbital-treated animals were 
perfused transcardially with 10% buffered formalin, and their brains were removed and 
preserved in buffered formalin for at least 48 hrs. The brains were then cut on a cryostat 
(40 µm sections) and stained by the cresyl violet method to verify the position of the 
cannula tip. Only those animals in which the cannulae terminated in the dorsal border of 
the PVN without damage to the PVN neurons were included in the statistical evaluation. 
G. PITHING PROCEDURES 
Pithed rats were prepared according to the method of Gillespie and Muir (85). The 
animals were anesthetized with ether, and the trachea cannulated. An aluminum pithing 
rod (2 mm diameter) was passed into the brain through the right orbit and advanced 
down the spinal cord to the sacral vertebrae for a total distance of 15 cm. The rats were 
immediately ventilated with Harvard Apparatus Rodent respirator (room air, 60 
strokes/min, approximately 1-1.2 ml/100 g body weight). Rectal temperature was 
maintained at 36-37 °C with a heating pad and a lamp. The pithing rod served as a 
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stimulating electrode, and another rod was inserted under the skin of the back to serve 
as an indifferent electrode for stimulation of the spinal cord. This pithing procedure 
destroys the entire central nervous system, but leaves the emerging nerve trunks intact. 
Since those parts of the pithing rod in the sacral and cervical regions of the spinal cord 
were coated with high resistance varnish, the stimulating current applied through the 
pithing rod was restricted to the thoracolumbar region where the sympathetic 
preganglionic fibers are located. After curare (3 mg/kg) was given via the dorsal vein of 
the penis to eliminate skeletal muscle contractions, the preganglionic thoraco-lumbar 
sympathetic nerves were stimulated at a constant rate (3 Hz, 10 V, and 0.5 msec) to 
maintain blood pressure at physiological levels. Some rats required small supplemental 
doses of curare. 
The advantages of using pithing combined with stimulation include: 1) sympathetic 
outflow can be maintained at a steady level by applying a constant stimulation to the 
sympathetic preganglionic fibers via the pithing rod, 2) basal blood pressure can be 
maintained at physiological levels, and 3) there are no centrally-mediated compensations. 
By using this model, the CNS mediated fluctuation in catecholamine release from the 
nerve terminals and the adrenal medulla is eliminated, thus, allowing the evaluation of 
the peripheral mechanisms of catecholamine release. 
H. ADRENAL GLAND DENERVATION 
Rats were anesthetized with sodium pentobarbital (60 mg/kg, i.p.). Under aseptic 
conditions, two flank incisions were made on both left and right sides of the back just 
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below the costal margin. With the aid of a microscope, the adrenal glands were isolated 
from the surrounding connective tissues except for the adrenal artery and vein. The 
splanchnic nerve fibers innervating the adrenal gland and any other fibers which might 
enter the adrenals without joining the splanchnic nerves were served. Extra care was 
taken to leave the vessels intact to avoid necrotic damage to the adrenal glands. Phenol 
(10%) was then applied on the surface of the glands and the vessels. Sham operations 
were performed by exposing the adrenal glands without dissecting the nerves. The 
incisions were closed in layers, and rats received 40,000 IU penicillin (i.m.). The 
denervation procedure required about 20 min to complete, and a two week recovery 
period was allowed before the experiment. 
The effectiveness of this adrenal denervation technique was verified in a separate 
group by demonstrating the failure of plasma epinephrine to become elevated in response 
to hemorrhage. Chronic adrenal denervated rats were subject to carotid artery cannulation 
and on the next day, the carotid cannula was extended to a 5 ml glass syringe via a PE-
200 tubing, both pre-rinsed with heparin. The syringe served as a blood reservoir and 
blood was allowed to flow in or out of the reservoir depending on the height of the 
syringe above the rat. The blood pressure was monitored on the Grass oscillograph using 
a stopcock. The rats were bled to 70 mmHg (total volume 4.5-5 ml) in about 10 min by 
adjusting the syringe position. Blood samples were taken at predetemined times (15, 60 
min) for catecholamine assay. Results showed that in sham denervated rats (n=3), 
hemorrhage induced significant elevations in plasma epinephrine (251 +60 pg/ml at 0 
min, 2286+465 pg/ml at 60 min) and norepinephrine (377+44 pg/ml at 0 min, 787+204 
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at 60 min). In contrast, plasma epinephrine elevations were abolished in adrenal 
denervated rats (n=3, 45+16 pg/ml at O min, 48+7 pg/ml at 60 min) while plasma 
norepinephrine was still increased (394+ 102 pg/ml at O min, 764+75 pg/ml at 60 min) 
in response to hemorrhage. 
I. BLOOD SAMPLE COLLECTION 
Arterial blood samples (500 µl) were collected at predetermined times and placed 
in 1.5 microcentrifuge tubes (Sarstedt) containing 10 µl solution consisting of 90 mg/ml 
ethyleneglycol-bis-(B-amino-ethyl ether)N,N'-tetraacetic acid (EGTA) and 60 mg/ml 
glutathione (pH 6-7). The plasma was separated following centrifugation (10,000 g x 2-3 
min, Eppendorf Model 5414 microfuge) and stored at -40 °C (Revco freezer) until 
analysis for catecholamines. A 500 µl volume of donor blood from normal rats or equal 
volume of saline-resuspended blood cells was infused into the venous line following each 
sample withdrawal. 
J. PLASMA CATECHOLAMINE ASSAY 
Plasma levels of norepinephrine and epinephrine were assayed according to the 
radio-enzymatic thin-layer chromatographic procedure described previously (189,193). 
Materials were supplied in kit form (Amersham, Arlington Heights, IL). This single 
isotope radioenzymatic method can measure epinephrine and norepinephrine 
simultaneously with a sensitivity of 2-5 pg per 50 µl sample (40-100 pg/ml plasma) and 
interassay variation of approximately 10%. The analysis is based on the use of the 
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isolated enzyme catecholamine-o-methyltransferase (COMT) to transfer a radioactive 
methyl group from S-adenosyl-L-methionine (3H-SAM) to an endogenous catecholamine 
acceptor molecule to form a O-methylcatecholamine derivative. In the presence of 3H-
SAM, epinephrine is converted to 3H-metanephrine and norepinephrine is converted to 
3H-normetanephrine. 
Duplicate 50 µl aliquots of each plasma sample were added to incubates containing 
(in final concentration) 100 mM Tris, 30 mM MgC12, 10 mM EGTA, 10 µl of COMT 
solution, 1 mM reduced glutathione, 5 µCi SAM (3H-methyl, 4.3-5.5 mM). Total volume 
was 100 µland pH was approximately 8.1-8.3. For every 5 samples, one sample was 
added to four tubes rather than duplicate tubes and 100 pg of epinephrine and 
norepinephrine were added to two of the four tubes as internal standards. Reagent blank 
was constituted by substituting distilled H2O for the plasma. 
The samples were incubated in a shaking water bath at 37 °C for 60 min. The 
reaction was stopped by addition of 50 µl of a solution consisting of 800 mM boric acid, 
80 mM ethylenediamine tetraacetic acid-disodium salt (EDTA-Na2) and 4 mM each of 
metanephrine and normetanephrine in 1 NaOH. The resulting solution (pH 10.0) was 
mixed vigorously for 15 sec with 2 ml of toluene/isoamyl alcohol (3:2, v:v). The 3H-
methoxycatecholamine derivatives are much more soluble in the organic phase than in 
aqueous phase. The aqueous and organic phases were separated by centrifugation (800 
g x 2 min, Model UV centrifuge, International Equipment Company). The aqueous phase 
was rapidly frozen in an ethanol/dry ice bath, and the organic phase was decanted into 
a tube containing 100 µl of 0.1 M acetic acid. The 3H-methylcatecholamine derivatives 
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were partitioned into the aqueous phase by mixing for 15 sec. The decrease in pH 
effected by the addition of acetic acid greatly reduced the solubility of the derivatives in 
the organic phase. After the tubes were centrifuged at 800 g for 2 min, the aqueous 
phase was quick-frozen, and the organic phase was discarded. One ml of the toluene-
isoamyl alcohol was added to the acetic acid mixture. After mixing, centrifugation and 
freezing the aqueous phase, the organic layers were aspirated and discarded. One 
hundred µl of ethanol was then added to the final extract and the solution was applied to 
a silica gel thin glass plate (Uniplate, Analtech) by use of 250 µl Hamilton syringes and 
a thin layer chromatograph (TLC) Multispotter (Analytical Instrumentation Specialties) 
while drying with a hot air blow dryer (60 °C). The plates were developed for 20-30 min 
in a paper-lined tank containing a solution of chloroform/t-amyl alcohol/methylamine 
(8/2/1, v/v/v). Two zones were visualized under 254 nm UV light. The upper zone 
contained metanephrine, and the lower zone contained normetanephrine. Each zone was 
then scraped from the plate into a correspondingly numbered scintillation vial. 
The further steps for epinephrine and norepinephrine assay were identical. One ml 
of0.05 M ammonium hydroxide was added to each vial to elute the amine from the silica 
gel. The 3H-catecholamine derivative was then oxidized to 3H-vanillin by addition of 50 
µl of sodium periodate for 5 min followed by the addition of 500 µl of 10% glycerol. 
The solution was acidified by the addition of 1 ml of 0.1 M acetic acid and vigorously 
mixing. Ten ml of toluene/liquiflor (1000:50) was added to each vial and 3H-vanillin was 
partitioned into the organic phase with 30 sec shaking. Liquiflor is a 2.5-
Diphenyloxazole--p-bis-[2-(5-phenyloxazolyl)]-benzene (PPO-POPPO) toluene 
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concentrate. Radioactivity in these samples was determined by a liquid scintillation 
counter (LKB Instruments Inc., MD). The sample plasma content for each catecholamine 
was calculated by computer using the following equation: 
catecholamine Concentration (pg/ml)= 
CPM sample-CPM blank pg standard 
X 
CPM (sample+standard)-CPM sample ml sample volume 
Above counts per min (CPM) value was the average from each set of duplicates. 
K. AGENTS 
1. Endotoxin {ETX): Lyophilized endotoxin derived from Salmonella enteritidis 
(lipopolysaccharide Boivin, control No. 723198) was purchased from Difeo Laboratories 
(Detroit, Ml). For use in intravenous administration, the lipopolysaccharide was prepared 
freshly in 0.9% sodium chloride (3 mg/ml for the dose of 5 mg/kg, and 1 mg/ml for the 
dose of 1.5 mg/kg). 
2. Interleukin-IP (IL-1/j): Human recombinant interleukin-1/j was purchased in a 
lyophilized form from Biosource International Inc. (Westlake Village, CA). The IL-1 was 
lot 215-llOC with specific activity 1 x107 unit/mg, as assessed by a mitogenic assay 
stimulating 3H-thymidine uptake into C3H/HFJ thymocytes. Endotoxin contamination was 
determined by Biosource to be less than 0.001 endotoxin units/µg (Limulus Amoebocyte 
Lystate Assay; 1 endotoxin unit = 0.1 ng of ETX). 
3. Interleukin-6 (IL-6): Human recombinant interleukin-6 was obtained in a lyophilized 
form from Biosource International Inc. (Westlake Village, CA). The lot No. was 216-
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0()2D, and the specific activity was 6 x 1()6 unit/mg as determined by stimulation of 3H-
tbymidine uptake by B9 cells. Endotoxin contamination was same as in IL-1. 
4. Tumor necrosis factor a (TNFa): Human recombinant tumor necrosis factor a was 
also purchased in a lyophilized form from Biosource International Inc. (Westlake Village, 
CA). The lot No. was 311-010D, and the specific activity was 1 x 1()8 unit/mg as 
determined by the cytolysis of murine L929 cells in the presence of Actinomycin-D. 
Endotoxin contamination was also less than 0.001 endotoxin units/µg. 
L. DATA ANALYSIS 
Data are expressed as mean+SEM. A p value less than 0.05 was considered to be 
statistically significant. Cardiovascular responses, percent change of sympathetic nerve 
activity and plasma catecholamines following test treatments were compared using 
analysis of variance with repeated measurements. Student-Newman-Keul's test was used 
for individual group comparisons. Blood pressure and associated heart rate as well as 
RSNA responses to phenylephrine or nitroglycerine infusion to assess baroreceptor 
denervation were compared between the SAD and sham groups with unpaired Student t 
tests. 
CHAPTER IV 
INVOLVEMENT OF CENTRAL VS. PERIPHERAL MECHANISMS 
IN MEDIATING SYMPATHOADRENAL ACTIVATION IN ENDOTOXIC RATS 
INTRODUCTION 
Gram-negative sepsis with ensuing septic shock is a persistent health problem 
accounting for the major cause of mortality in hospitalized patients (1,32). Numerous 
studies have linked gram-negative bacterial endotoxins to the pathogenesis of sepsis 
(103,104,167,171), which supports the use of the endotoxic animal model for studying 
the basic pathophysiologic process of septic shock. 
Studies of sepsis or endotoxicosis in either clinical or experimental situations have 
demonstrated a marked sympathoadrenal activation. Supportive evidence includes 
elevations of plasma catecholamines ( 17, 94, 113, 114, 134), an enhanced norepinephrine 
turnover (188), augmented sympathetic nerve discharges (92,159,185) as well as 
depletion of the tissue catecholamine content in the end stage of septic shock (96,187). 
This sympathoadrenal activation may support the cardiovascular and metabolic 
adjustments to septic challenge, but overwhelming and sustained activation may 
contribute to the irreversibility of the shock process (31, 88, 125, 148). 
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Mechanisms responsible for mediating the sympathoadrenal activation during 
endotoxicosis are largely unknown. Norepinephrine release from the sympathetic nerve 
terminals and epinephrine release from the adrenal medulla are most likely neurally-
controlled via post ganglionic sympathetic nerves and preganglionic adrenal sympathetic 
nerves, respectively. The critical role of centrally-mediated mechanisms and neural 
dependence of the sympathetic activation during developing endotoxic shock have been 
demonstrated in previous studies (71,150,176,253). However, recent experimental 
findings suggest that peripheral modulation of catecholamine secretion from the adrenal 
medulla during endotoxic shock may also be present (112,211). Non-neurogenic 
stimulation of adrenal epinephrine secretion is suggested by evidence that ganglionic 
blockade could not prevent catecholamine release from the adrenal medulla (211), and 
in vitro incubation of adrenal chromaffin cells with endotoxin or other endotoxin-
elaborated agents enhance catecholamine secretion (130,141,177,225). 
Thus, the purposes of the present study were: 1) to clarify whether both central and 
peripheral mechanisms are involved in mediating plasma catecholamine responses during 
endotoxicosis, 2) to assess the relative contributions of each of the mechanisms to 
elevations in plasma norepinephrine and epinephrine following endotoxic challenge, and 
3) to examine the neurogenic or non-neurogenic characteristics of peripheral modulations 
of adrenomedullary release following endotoxin, if the modulation indeed exists. 
Specifically, plasma catecholamine responses to endotoxin challenge were compared 
between rats with and without central regulatory mechanisms, i.e. conscious and pithed 
rats, to assess the contribution of central mechanisms. It was hypothesized that the major 
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elevation of plasma catecholamines depends on centrally-mediated mechanisms such that 
destruction of the central nervous system (by pithing) would significantly diminish the 
endotoxin-induced elevation in plasma catecholamines. Meanwhile, pithed rats with 
constant stimulations of the sympathetic chain do not have centrally-mediated fluctuations 
in sympathetic outflow and, thus, permit the evaluation of peripheral modulation of 
catecholamine release. It was hypothesized that peripheral modulations of the adrenal 
medulla are present, which would result in significant elevation of plasma epinephrine 
in pithed rats following administration of endotoxin. The possibility of non-neurogenic 
catecholamine secretion from the adrenal gland was further studied in pithed animals as 
well as conscious rats by means of adrenal denervation. 
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MATERIALS AND METHODS 
Experimental Protocols 
Two sets of experiments were conducted in male rats weighing 407+ 10 grams. In 
the first experiment sympathoadrenal responses were assessed in pithed, endotoxic rats 
with intact or denervated adrenal glands. Under pentobarbital anesthesia, bilateral adrenal 
glands were denervated or sham-operated and penicillin (40,000 JU) was given i.m. 
following the surgery. After two weeks of recovery, experiments were performed. Rats 
were pithed under ether anesthesia and immediately ventilated (60 strokes/min, 1-1.2 
ml/100 g body weight). After administration of curare, the thoraco-lumbar preganglionic 
sympathetic nerve fibers were stimulated at a constant rate (3 Hz, 10 V, and 0.5 msec). 
Carotid artery and jugular vein were then cannulated. Following a 30 min equilibration 
period, endotoxin (1.5 mg/kg) was given intravenously to both adrenal sham-operated 
rats (n=8) and adrenal denervated rats (n=7). Saline treated sham (n=5) and adrenal 
denervated (n=4) rats served as controls. The hemodynamic response was assessed at 
0, 30, 60 and 90 min, and plasma catecholamines were determined at 0, 60 and 90 min 
post endotoxin. Rectal temperature was maintained at 36-37 °C using a heating pad and 
a lamp throughout the protocol. 
In the second experiment sympathoadrenal responses were evaluated in conscious 
rats with intact or denervated adrenal glands. Under halothane anesthesia chronically 
adrenal sham-operated or denervated rats underwent implantation of arterial and venous 
cannulae, and experiments were conducted the following day. Endotoxin was given 
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intravenously (1.5 mg/ml) to both sham operated (n=5) and denervated rats (n=5). 
saline treated sham {n=5) and denervated {n=4) rats served as controls. Hemodynamic 
responses and plasma catecholamines were also assessed at 0, 30, 60, and 90 min post 
endotoxin. 
Pithing Procedures 
Pithed rats were prepared according to the method described in chapter III. Briefly, 
after cannulation of the trachea under ether anesthesia, rats were pithed by inserting an 
aluminum rod through the orbit and foramen magnum, down the spinal cord to the sacral 
vertebrae. The pithing rod served as a stimulating electrode, and another rod inserted 
under the back skin served as an indifferent electrode for stimulation of the sympathetic 
chain. After minimizing skeletal muscle contraction with curare (3 mg/kg, i.v.), the 
preganglionic thoraco-lumbar sympathetic nerves were stimulated at a constant rate (3 
Hz, 10 V, and 0.5 msec) to maintain blood pressure at physiological levels and to 
eliminate the fluctuations of catecholamine secretions. 
Adrenal Gland Denervation 
As described in general methods, bilateral adrenal glands were denervated by 
severing all the surrounding connective tissues which contain the nerve fibers innervating 
the adrenals. Extra care was taken to leave the blood vessels intact to avoid necrotic 
damage to the adrenal glands. Phenol (10%) was then applied on the surface of the 
glands and the vessels. Sham operations were performed by exposing the adrenal glands 
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without dissecting the nerves. Two week recovery period was allowed before 
experiments. The effectiveness of this adrenal denervation technique was verified, in a 
separate group, by demonstrating the failure of the plasma epinephrine elevation in 
response to hemorrhage-induced hypotension (see Chapter III for details). 
Blood Sample Collection and Catecholamine Assay 
Arterial blood samples (500 µl) were collected at pre-determined times and treated 
as described in chapter III. A 500 µl volume of donor blood from normal rats was 
infused into the venous line following each sample withdrawal. Plasma levels of 
norepinephrine and epinephrine were assayed in duplicate 50 µl samples using the radio-
enzymatic thin-layer chromatographic procedure described in general methods. 
Materials 
Endotoxin (derived from S. enteritidis) was prepared freshly in 0.9% saline (1 
mg/ml). Materials for catecholamine assay were obtained in kit form from Amersham 
(Arlington Heights, IL). 
Data Analysis 
Data are expressed as mean+SEM (n). A p value less than 0.05 was considered to 
be statistically significant. Cardiovascular responses and plasma catecholamines were 
compared using analysis of variance with repeated measurements and Student-Newman-
Keul 's test for individual comparisons. 
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RESULTS 
Hemodynamic and Sympathetic Responses in Pithed Rats Following Endotoxin 
Thirty minutes after pithing, arterial blood pressure and heart rate in all animals 
with constant stimulation reached steady-state levels. As presented in figure 4-1, baseline 
mean blood pressure were not different between the groups. The mean blood pressure 
was within physiological range (100-120 mmHg), indicating that this level of electrical 
stimulation to the sympathetic chain was adequate to maintain the blood pressure in 
pithed rats comparable to levels in conscious rats. There was a gradual decline of the 
blood pressure with time in saline treated animals, as indicated in figure 4-1 where MBP 
was decreased from baseline value of 110+ 10 to 88+6 mmHg at 90 min in sham rats 
and 99 + 3 to 87 + 10 mmHg in denervated rats. By contrast, in both adrenal sham 
operated and denervated rats, intravenous endotoxin treatment induced much greater drop 
in MBP than the time-related fall. The decrease in MBP was similar in sham and 
denervated groups given endotoxin, from pretreatment values of 107+4 and 117+5 
mmHg to 42+3 and 41 +4 mmHg at 90 min, respectively. There were no differences in 
baseline heart rate between the groups. Heart rate was significantly accelerated to 
comparable levels at 60 and 90 min following endotoxin injection in sham and denervated 
rats. Saline treatment did not affect the heart rate during the protocol. 
In both adrenal sham-operated and denervated animals, plasma norepinephrine was 
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Figure 4-1.Mean blood pressure (MBP) and heart rate (HR) responses in pithed rats with 
adrenal denervation (ADR DENERY) or sham operation (ADR SHAM) following 
intravenous endotoxin (ETX, 1.5 mg/kg) or saline. x: p<0.05 for both ADR DENERY 
and ADR SHAM post endotoxin vs. 0 min; $: p < 0.05 for both ADR DENERY and 
ADR SHAM post saline vs. 0 min. 
63 
(figure 4-2). In contrast, intravenous endotoxin induced mild and similar increase in 
plasma epinephrine in both sham and denervated groups. Ninety min after endotoxin 
injection, plasma epinephrine was increased from pretreatment value of 153+ 19 and 
125+38 to 376+87 and 463+ 137 pg/ml in sham and denervated groups, respectively. 
Saline treatment in sham and denervated animals altered neither plasma norepinephrine 
nor epinephrine. 
Hemodynamic and Sympathetic Responses in Conscious Rats Following Endotoxin 
In conscious sham-operated animals, intravenous endotoxin induced a significant 
drop in blood pressure at 60 min post treatment, which recovered at 90 min to a level 
not different from the baseline value (figure 4-3). In adrenal denervated conscious rats, 
however, hypotension appeared at 30 min following endotoxin injection, which was 
significantly lower compared to MBP in the sham group. Furthermore, the denervated 
animals remained in a hypotensive state thereafter with slight recovery at 90 min. In both 
sham and denervated groups, endotoxin treatment evoked a significant tachycardia as 
indicated in figure 4-3 at 30, 60 and 90 min post injection. The heart rate was 
significantly higher in denervated rats at 60 min in comparison to sham animals. Saline 
controls of both sham and denervated rats showed no alterations in MBP and heart rate. 
Plasma catecholamine response to endotoxin challenge in conscious rats is presented 
m figure 4-4. In both adrenal sham-operated and denervated animals, plasma 
norepinephrine was similarly and significantly enhanced from baseline values 
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Figure 4-2. Plasma norepinephrine (NE) and epinephrine (EPI) responses in pithed rats 
with adrenal denervation (ADR DENERY) or sham operation (ADR SHAM) following 
intravenous endotoxin (ETX, 1.5 mg/kg) or saline. x: p < 0.05 both ADR DENERY and 
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Figure 4-3. Mean blood pressure (MBP) and heart rate (HR) responses in conscious 
rats with adrenal denervation (ADR DENERY) or sham operation (ADR SHAM) 
following intravenous endotoxin (ETX, 1.5 mg/kg) or saline. *: p < 0.05 for ADR 
DENERY post endotoxin vs. 0 min;#: p<0.05 for ADR SHAM post endotoxin vs. 0 
min; +: p<0.05 for endotoxin-treated ADR DENERY vs. ADR SHAM. 
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following endotoxin throughout the 90 min protocol. Although the norepinephrine level 
at 90 min in denervated group appeared to be higher than that in the sham group, the 
multivariate ANOV A with repeated measures did not indicate a significant difference, 
most likely due to the high variance in the denervated group. The response pattern of 
plasma epinephrine was dramatically different between the sham group and the 
denervated group. As shown in figure 4-4, in sham animals, plasma epinephrine was 
markedly elevated at 30 min following endotoxin and remain elevated thereafter. The 
maximum increment, approximately 12-13 fold above control, was achieved 30-60 min 
post endotoxin after which the increase diminished, but remained 4 fold higher than 
baseline value at 90 min. In contrast, in adrenal denervated rats, the same dose of 
endotoxin did not induce significant enhancement of plasma epinephrine until 90 min post 
injection where the increment was not different from that in sham rats. Saline treatment 
to both sham and denervated animals did not have any significant effects on plasma 
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Figure 4-4. Plasma norepinephrine (NE) and epinephrine (EPI) responses in conscious 
rats with adrenal denervation (ADR DENERY) or sham operation (ADR SHAM) 
following intravenous endotoxin (ETX, 1.5 mg/kg) or saline. x: p < 0.05 for both ADR 
DENERY and ADR SHAM post endotoxin vs. 0 min;*: p<0.05 for ADR DENERY 
post endotoxin vs. 0 min; #: p < 0.05 for ADR SHAM post endotoxin vs. 0 min; +: 
p<0.05 for endotoxin-treated ADR DENERY vs. ADR SHAM. 
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DISCUSSION 
The data presented in this study demonstrated that in pithed rats with no central 
regulatory mechanisms, intravenous endotoxin did not increase plasma norepinephrine 
during the 90 min protocol. However, endotoxin administration did induce a 2 to 3 fold 
elevation in plasma epinephrine at 90 min post injection. In contrast, data from the 
present and previous studies (114) showed that in intact conscious rats, both plasma 
norepinephrine and epinephrine were markedly elevated 30 min following endotoxin 
(figure 4-4). Thereafter, plasma norepinephrine remained elevated, and epinephrine 
declined gradually but was still significantly above pre-treatment controls. These results 
suggest that increases in plasma norepinephrine during endotoxicosis, largely elaborated 
from sympathetic nerve terminals, depend on central mechanisms. Increases in plasma 
epinephrine with endotoxin, primarily released from the adrenal medulla, were shown 
to involve both central and peripheral regulations with central mechanism being 
dominant. This is demonstrated by the much lower and delayed elevation of plasma 
epinephrine in pithed rats (figure 4-2) compared to conscious rats following endotoxin 
(figure 4-4). Since endotoxin induced a similar elevation in plasma epinephrine in pithed 
rats both with and without adrenal innervation, it appears that peripheral mechanisms 
involve non-neurogenic modulation of release. This non-neurogenic adrenal epinephrine 
release was further substantiated in conscious, adrenal denervated rats, which accounted 
for 1/3 of the maximum epinephrine response as observed in intact rats (figure 4-4). 
Consistent with the finding in pithed rats, the epinephrine elevation in adrenal denervated 
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conscious rats also showed a lower magnitude and a delayed time course compared to 
intact animals. These results imply that central mechanisms are primarily responsible for 
the early epinephrine increments during endotoxicosis whereas the peripheral modulation 
contributes to the more prolonged plasma epinephrine elevation. 
The present results are in agreement with previous reports where the crucial 
involvement of the central nervous system in the sympathoadrenal response during 
endotoxicosis was demonstrated. For example, acute lesion of the cerebellar fastigial 
nuclei in the dog prevents the recovery and maintenance of blood pressure following 
endotoxin-induced hypotension (149), suggesting that the sympathetic response to 
endotoxin challenge requires intact central regulatory mechanisms. Intact spinal cord also 
seems critical to endotoxin-evoked sympathetic response. Spinal transection at the C-7 
level in dogs abolished the catecholamine release during endotoxicosis (71), implying that 
endotoxin-elicited sympathoadrenal response was presumably dependent on descending 
spinal pathways. Section of the splanchnic nerves in the dog eliminated the elevation of 
plasma epinephrine (176), and acute denervation of hemi-spleen protected against the 
norepinephrine depletion (253). These results suggest that increased catecholamine release 
during septic shock depends on nerve activation. 
Unlike the present study, these authors did not report the non-neurogenic modulation 
of epinephrine release from the adrenal glands. This may be attributable to the fact that 
animals species, doses of endotoxin and sampling time course used in the present study 
and previous studies are different. Most importantly, it is noteworthy that the animal 
numbers in the previous studies were small (n=2-3) and the results were variable. 
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Furthermore, the catecholamine assay used in their studies (biological or floremetric 
assay) was less sensitive. 
The peripheral modulation of epinephrine secretion has been previously reported in 
pithed, endotoxic rats (112), but it was not known whether this modulation was neurally 
or non-neurally mediated. In both previous and present studies using pithed rats, 
sympathetic outflow to the adrenal glands was maintained at steady state levels by 
applying constant electrical stimulation to the paravertebral sympathetic chain. In those 
animals endotoxin-induced adrenal modulation could be due to an enhanced epinephrine 
release per nerve impulse or local modulation within the glands independent of nerve 
activity. The data from adrenal denervated rats in the present study suggest that such 
peripheral modulation is most likely non-neurogenic. Although incomplete adrenal 
denervation could account for epinephrine elevation with endotoxin, this is unlikely to 
be the case in the present study. First, the adrenal denervation completely abolished the 
increases in plasma epinephrine in response to hemorrhage-induced hypotension. 
Secondly, 90 min following endotoxin, adrenal denervated animals showed similar, rather 
than attenuated, epinephrine response compared to adrenal intact animals. The non-
neurogenic stimulation of the adrenal epinephrine secretion has also been reported in a 
previous study in that ganglionic blockade could not prevent catecholamine release from 
the adrenal glands during endotoxicosis in newborn rats (211). 
One possible mechanism for the endotoxin-mediated non-neurogenic release may 
involve decreased oxygen supply to the adrenal medulla as a consequence of circulatory 
hypoxia and diminished blood flow. Hypoxia has been shown to be a potent stimulus for 
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adrenal catecholamine secretion in newborn rats (212), but in adult rats hypoxia effects 
are not prominent on catecholamine release from the adrenal gland (212). Alternatively, 
certain endogenous substances released into the circulation during endotoxicosis have also 
been demonstrated to act directly on the adrenal gland or cultured adrenal chromaffin 
cells to stimulate catecholamine secretion. Those substances include histamine, 
bradykinin, angiotensin, prostaglandins, and vasoactive intestinal polypeptide 
(130,141,153,177). Prolonged incubation of adrenal chromaffin cells with endotoxin in 
vitro also enhanced catecholamine release (225). Recent studies have shown that protein 
kinase C might be involved in endotoxin effects and activation of protein kinase C is 
associated with enhanced catecholamine release from cultured chromaffi.n cells (151,229). 
The nature of the involvement of the central nervous system in mediating the 
sympathoadrenal activation during endotoxicosis is unknown. Although endotoxin-induced 
hypotension may unload the arterial baroreceptors and result in the sympathoadrnal 
activation via baroreflex deactivation, numerous studies have shown that the 
sympathoadrenal system can still be markedly activated during endotoxicosis in the 
absence of hypotension or remain activated after restoration of blood pressure (115,185). 
Acidosis with resultant alteration in pH may also increase the sympathetic outflow, 
possibly via stimulating the peripheral or central chemoreceptors (50). The activation of 
the hypothalamic-pituitary-adrenal axis, which frequently occurs in sepsis, has been 
linked to the activation of the sympathoadrenal system (38). Recent studies have 
suggested that most endotoxin effects are mediated by releasing cytokines (79). Some of 
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the cyktokine effects involve the central nervous system and may be initiated in the brain 
(118,194). Elevation of plasma catecholamines following systemic or 
intracerebroventricular administration of tumor necrosis factor or interleukin-! has been 
demonstrated (21,202,213,236). 
Hemodynamic responses to endotoxin challenge in the present study appeared to 
follow the circulating catecholamine levels. Intravenous administration of endotoxin to 
pithed rats reduced the arterial blood pressure in a more rapid and severe manner and 
without a transient recovery compared with conscious or anesthetized rats receiving 
similar dose of endotoxin (114). Such results may be accounted for by the elimination 
of centrally-mediated compensatory mechanisms such as the major elevation of plasma 
catecholamines as a consequence of pithing. Thus, pithed rats are much susceptible to 
endotoxin insult. The late tachycardia in pithed rats was presumably due to the late 
increased circulating epinephrine from the adrenal gland. The hypotension and 
tachycardia responses following endotoxin in conscious animals were consistent with 
many previous results (113,114). The earlier and more profound endotoxin-induced 
decreases in MBP in denervated animals compared with sham rats are apparently 
attributable to the abolition of neurally mediated early epinephrine response. The 
explanation for greater tachycardia response at 60 min post endotoxin in denervated rats 
in comparison to that in sham rats is not clear. 
Results from the present experiments suggest that plasma norepinephrine response 
to endotoxic challenge is solely mediated by central mechanisms whereas epinephrine 
response involves both central and peripheral regulations. Centrally-mediated mechanisms 
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are dominant and responsible for the major and early elevation of circulating epinephrine. 
Peripheral modulation of adrenal epinephrine secretion, most likely non-neurogenic, 
contributes to a lesser and prolonged epinephrine response during endotoxicosis. 
CHAPTER V 
PLASMA CATECHOLAMINE RESPONSE IN SINOAORTIC 
DENERVATED RATS FOLLOWING ENDOTOXIN 
INTRODUCTION 
Hyperactivation of the sympathoadrenal system is generally considered to be one of 
the important pathogenic components during the development of septic shock 
(157,176,251). The signals responsible for mediating the sympathoadrenal activation 
during septic challenge are not clear and are basically unexplored. Since hypotension 
typically occurs along with increases in heart rate, sympathetic discharge and plasma 
catecholamines during endotoxicosis (93,113,185), it is possible that endotoxin-induced 
hypotension may be the primary cause of this activation by deactivating arterial 
baroreflexes. It is also important to recognize that in addition to hypotension, decreased 
pulsatile pressure without significant changes in mean blood pressure reduces the 
baroreceptor activity as well (46,47, 70). A study reported by Chapleau et al. (48) showed 
that an endogenous factor derived from activated endothelial cells also diminished the 
baroreceptor afferent discharge. These findings may have implications in the sympathetic 
activation during sepsis, such that baroreflex deactivation, as a result of decreased 
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baroreceptor activity, may contribute to the enhanced sympathetic outflow. 
A variety of experimental findings have challenged the concept that hypotension-
induced baroreflex deactivation is a dominant factor in mediating sympathoadrenal 
response during septic shock. In rats treated with E. coli bacteria, plasma catecholamines 
are markedly elevated while blood pressure is not significantly altered (115). In 
experiments involving bolus administration of endotoxin to conscious rats, plasma 
catecholamines were markedly elevated before hypotension occurred (114). Direct nerve 
recording in endotoxic animals indicated that increased sympathetic discharges took place 
prior to the onset of hypotension and additional increases in nerve activity occurred 
following the fall in blood pressure (185). This activity persisted after blood pressure was 
restored to basal levels by volume infusion. Collectively, such evidence suggests that 
hypotension does not necessarily initiate or maintain the increased plasma catecholamines 
which occur with septic insult. 
The aim of the present study was to examine the role of arterial baroreceptors in 
mediating sympathoadrenal activation during endotoxicosis by using acutely, as well as 
chronically, sinoaortic-baroreceptor-denervated rats. It was hypothesized that baroreflex 
deactivation may not be the major factor in mediating the sympathoadrenal activation 
during developing endotoxic shock and, thus, the denervation of the arterial baroreceptors 
would not eliminate the marked elevation of plasma catecholamines that occurs following 
administration of endotoxin. Since endotoxin will initiate dramatic increases in plasma 
catecholamines in rats, experiments were designed to treat all animals with endotoxin and 




MATERIALS AND METHODS 
Experimental Protocols 
Three groups of experiments were conducted in male rats weighing 386+ 12 grams. 
The first group of experiments were performed in acutely sinoaortic baroreceptor 
denervated rats to obtain a preliminary assessment of the baroreceptor role in mediating 
the sympathoadrenal activation during endotoxicosis. Bilateral sinoaortic denervation 
(SAD, n=6) or sham operation (SHAM, n=6) was performed under xylazin (10 mg/kg, 
i.p.) and a-chloralose (70 mg/kg, i.p.) anesthesia as described below. Femoral arterial 
and venous cannulae were implanted, and baroreceptor reflexes were tested to confirm 
the completeness of SAD. After approximately 1.5 hours equilibration, endotoxin (5 
mg/kg) was injected intravenously. MBP and HR were recorded continuously, and 
arterial blood samples were collected at 0, 30, 60, and 90 minutes after endotoxin 
administration. 
The second group of experiments were performed in chronically sinoaortic 
baroreceptor denervated rats. This design was employed to prevent possible misleading 
results as a consequence of anesthesia and acute surgery. SAD and sham operation were 
performed as in acute preparations, and both groups of animals received 40,000 U 
penicillin (i.m.) following the surgery. After a 2-4 week recovery period, all rats 
underwent surgical implantation of femoral arterial and venous cannulae under halothane 
anesthesia (2.0% in oxygen). On the following day, baroreflexes were tested to confirm 
the SAD as described before. Endotoxin (5 mg/kg) was then given intravenously to both 
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SAD {n=4) and sham (n=5) rats. MBP and HR were recorded continuously, and blood 
samples were taken at 0, 30, 60, and 90 minutes after endotoxin administration. Separate 
groups of SAD (n=4) and sham animals {n=5) were given saline in place of endotoxin 
and were followed during the course of above protocol with subsequent sample collection 
and analysis. 
The third group of experiments were designed to assess the singular contribution of 
hypotension-induced baroreceptor reflexes to the sympathetic activation in the absence 
of endotoxin treatment. The cardiovascular and sympathoadrenal responses of rats with 
either SAD (n=5) or sham operation (n=5) to hypotension induced by hydralazine, a 
vasodilator, were determined. The animals were prepared as in the second group of 
experiments, and on the day of the experiment, the baroreceptor reflex testing confirmed 
the completeness of the denervation. Hydralazine (1 mg/kg) was given intravenously as 
a bolus injection, and MBP and HR were monitored continuously and blood samples 
were taken at 0, 15, and 30 minutes. 
Sinoaortic Baroreceptor Denervation 
Sinoaortic baroreceptor denervation (SAD) was performed as described in chapter 
ill. For aortic baroreceptor denervation, the superior laryngeal nerves, the aortic 
depressor nerves, and the superior cervical ganglia including a small segment of 
sympathetic chain were sectioned. For carotid sinus denervation, all connective tissue and 
nerve fibers were stripped from the thyroid, occipital, internal, external and common 
carotid arteries. Sham operation was performed by exposing the carotid sinuses bilaterally 
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without dissection of the region. Completeness of baroreceptor denervation was verified 
by determining the reflex changes in heart rate following pharmacological alterations in 
blood pressure. See general methods for details. 
Blood Sample Collection and Catecholamine Assay 
Arterial blood samples (500 µl) were collected at pre-determined times and treated 
as described in chapter m. Plasma levels of norepinephrine (NE) and epinephrine (BPI) 
were assayed in duplicate 50 µ1 samples using the radio-enzymatic thin-layer 
chromatographic procedure described in general methods. 
Materials 
Endotoxin (derived from~ enteritidis) was prepared fresh daily in 0.9% saline (3 
mg/ml). Hydralazine was obtained in 20 mg/ml vial and diluted with saline to 1 mg/ml 
for i. v. injection. Materials for catecholamine assays were obtained in kit form from 
Amersham (Arlington Heights, IL). 
Data analysis 
Data are expressed as Mean+SEM (n). A p value less than 0.05 was considered to 
be statistically significant. Cardiovascular responses and plasma catecholamines following 
endotoxin or hydralazine were compared using analysis of variance with repeated 
measurements and student-Newman-Keul's test for individual comparisons. Blood 
pressure and associated heart rate response to phenylephrine or nitroglycerine infusion 
80 
to assess baroreceptor denervation were compared between the SAD and sham groups 
with unpaired student t tests. 
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RESULTS 
Effects of SAD on Baroreflex Control of Heart Rate 
Effectiveness of the baroreceptor reflex was tested in all denervated and sham 
animals. Pharmacologic-induced changes in blood pressure were very transient lasting 
only a few minutes. As presented in figure 5-1, the increase in MBP induced by 
phenylephrine was not different between sham and SAD rats in either acute or chronic 
preparations although the chronic animals appeared to have a greater increase than the 
acute preparations. Nitroglycerine also caused a similar fall in MBP in acutely prepared 
SAD and sham animals, whereas it induced a slightly greater drop of MBP in chronic 
SAD compared to sham rats. Both acute and chronic SAD eliminated the bradycardia 
caused by the phenylephrine-induced hypertension and the tachycardia associated with 
the nitroglycerine-induced hypotension. In contrast, phenylephrine and nitroglycerine 
infusion evoked significant bradycardia and tachycardia, respectively, in sham-treated 
animals. Low control values of plasma catecholamines prior to the administration of 
endotoxin to either SAD or sham group suggest that there were no prolonged effects of 
the transient manipulation of blood pressure to test baroreceptor reflexes. 
Effects of Acute SAD on Hemodynamic and Sympathoadrenal Activation during 
Endotoxicosis 
The repeated measures ANOV A showed that the pattern of blood pressure responses 
at various times following endotoxin was the same in SAD and sham animals. Within 
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Figure 5-1. Changes of mean blood pressure (MBP) and heart rate (HR) in response 
to intravenous phenylephrine and nitroglycerine infusion in acute sham operation (A-
SHAM), acute sinoaortic denervation (A-SAD), chronic sham operation (C-SfIAM) and 
chronic sinoaortic denervation (C-SAD) groups. #: p<0.05 for A-SAD vs. A-SHAM; 
*: p < 0.05 for C-SAD vs. C-SHAM. Unpaired-student t test. 
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each group (i.e. SAD or sham) there were no differences in MBP at 0, 30, 60 and 90 
minutes post endotoxin (figure 5-2). However, there was a significant overall difference 
(regardless of time) in blood pressures between the SAD and the sham groups following 
endotoxin administration. This difference can be seen in figure 5-2, where MBP was 
always lower in the sham group compared to the SAD group. HR was significantly 
increased (above baseline values) in SAD animals at 30, 60 and 90 minutes post 
endotoxin, whereas in the sham group, HR was significantly greater at 60 and 90 minutes 
compared to both 0 and 30 minutes. 
As shown in figure 5-3, the pattern of plasma catecholamine response following 
endotoxin exposure was similar in SAD versus sham animals. In both groups, plasma NE 
and BPI become significantly elevated at 30, 60 and 90 min following endotoxin (figure 
5-3). 
Effects of Chronic SAD on Hemodynamic and Sympathoadrenal Activation during 
Endotoxicosis 
The pattern of blood pressure responses to endotoxin treatment was not altered by 
chronic SAD compared to sham group (figure 5-4). Endotoxin treatment did not induce 
significant hypotension in either group. Pre-endotoxin HR was higher in SAD rats 
compared with sham rats. There was also a gradual increase in HR with time following 
endotoxin administration in the sham group but not in the SAD group (figure 5-4). 
As indicated in figure 5-5, the SAD and sham groups had a similar pattern of 
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Figure 5-2. Mean blood pressure (MBP) and heart rate (HR) responses in anesthetized 
rats with acute sinoaortic denervation (SAD) or acute sham operation (SHAM) following 
intravenous endotoxin (ETX, 5 mg/kg) or saline. *: p < 0.05 for SAD post endotoxin vs. 
0 min;#: p<0.05 for SHAM post endotoxin vs. 0 min. 
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Figure 5-3. Plasma norepinephrine (NE) and epinephrine (EPI) concentrations in 
anesthetized rats with acute sinoaortic denervation (SAD) or acute sham operation 
(SHAM) following intravenous endotoxin (ETX, 5 mg/kg) or saline. x: p < 0.05 for both 
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Figure 5-4. Mean blood pressure (MBP) and heart rate (HR) responses in conscious 
rats with chronic sinoaortic denervation (SAD) or chronic sham operation (SHAM) 
following intravenous endotoxin (ETX, 5 mg/kg) or saline. #: p < 0.05 for SHAM post 
endotoxin vs. 0 min. +: p<0.05 for endotoxin-treated SAD vs. SHAM. 
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had higher plasma BPI than sham animals at 30 min, lack of statistical difference in the 
between the two groups. Following endotoxin treatment, there were marked elevation 
plasma catecholamines in both SAD and sham groups over time, i.e. plasma NE and BPI 
at 30, 60 and 90 minutes post endotoxin were significantly increased compared to 
baseline values (figure 5-5). Saline-treated SAD and sham rats (as controls) showed no 
alterations in blood pressure, heart rate or plasma catecholamines during the experimental 
protocol. 
Effects of SAD on Hemodynamic and Sympathoadrenal Response to Hydralazine 
To test the degree of hypotension-induced sympathoadrenal activation with and 
without baroreceptor denervation in the absence of endotoxin, measurements of 
hemodynamic and plasma catecholamines were made following intravenous administration 
of hydralazine (1 mg/kg). This treatment caused a rapid and persistent reduction in mean 
blood pressure of both SAD and sham groups over 30 minutes (figure 5-6). However, 
the decrease in blood pressure was greater in the SAD compared to the sham group at 
5, 10, 15 and 20 minutes post injection, with a peak fall to 63+4 mmHg in the SAD and 
78 + 3 mmHg in the sham animals. This more profound hypotension in the SAD group 
is most likely due to the absence of baroreflex compensation for the blood pressure fall. 
The decreases in blood pressure were associated with increases in heart rate in both 
groups over time (figure 5-6). Although the sham group exhibited sustained tachycardia 
while the SAD animals showed variable changes in heart rate post hydralazine, the 
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Figure 5-5. Plasma norepinephrine (NE) and epinephrine (EPI) concentrations in 
conscious rats with chronic sinoaortic denervation (SAD) or chronic sham operation 
(SHAM) following intravenous endotoxin (ETX, 5 mg/kg) or saline. x: p<0.05 for both 
SAD and SHAM post endotoxin vs. 0 min. 
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Figure 5-6. Mean blood pressure (MBP) and heart rate (HR) responses in conscious 
rats with chronic sinoaortic denervation (SAD) or sham operation (SHAM) following 
hydralazine infusion (1 mg/kg, i.v.). *: p<0.05 for SAD post hydralazine vs. 0 min;#: 
p<0.05 for SHAM post hydralazine vs. 0 min; +: p<0.05 for SAD vs. SHAM; x: 
p<0.05 for both SAD and SHAM post hydralazine vs. 0 min. 
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the relatively high total variance. SAD treatment did alter the response pattern of plasma 
catecholamines to hydralazine compared to the sham. 
As shown in figure 5-7, plasma NE and EPI of the sham group were markedly 
elevated at 15 and 30 minutes following hydralazine-induced hypotension, whereas in the 
SAD group, plasma NE and EPI were not significantly elevated in response to a greater 
drop in blood pressure. This indicates that SAD treatment greatly reduced the 
hypotension-induced baroreflex-mediated sympathoadrenal activation. Furthermore, the 
increases in plasma catecholamines of the SAD rats were significantly less than that of 
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Figure 5-7. Plasma norepinephrine (NE) and epinephrine (EPI) concentrations in 
conscious rats with chronic sinoaortic denervation (SAD) or sham operation (SHAM) 
following hydralazine infusion (1 mg/kg, i.v.). #: p<0.05 for SHAM post hydralazine 
vs. 0 min. +: p<0.05 for SAD vs. SHAM. 
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DISCUSSION 
The mechanisms responsible for mediating the sympathoadrenal activation during 
endotoxicosis are not clear. It is expected that a decrease in systemic blood pressure 
induced by endotoxin would unload the arterial baroreceptors and reflexly enhance 
sympathetic outflow. Previous studies by Halinen et al. (92,93) demonstrated that 
endotoxin administration induced a drop of blood pressure in anesthetized dogs and cats, 
which was associated with cessation of the aortic arch baroreceptor afferent impulses and 
increased cardiac sympathetic efferent nerve discharges during their 15 minute protocol. 
The authors concluded that the sympathetic pathways were primarily activated through 
cardiovascular receptor reflexes to maintain blood pressure. However, they did not report 
what happened later than 15 minutes. Furthermore, their findings did not necessarily 
demonstrate baroreflex mechanism as an exclusive mechanism for sympathoadrenal 
activation during endotoxicosis or rule out the possibility of other parallel mechanisms 
for initiating the increased central sympathetic outflow. 
The experimental data presented here show that SAD treatment did not significantly 
alter the response pattern of plasma catecholamines to endotoxin when compared to 
sham-operated controls. Although in both figure 5-3 and 5-5 it would appear that 
endotoxin induced plasma epinephrine elevations were greater at early stage in denervated 
rats compared to sham rats, the change was in a direction opposite from that anticipated 
if baroreceptors primarily mediate the sympathetic response. It is also important to 
recognize that the hemodynamic and sympathetic alterations observed in the present study 
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are due to the effects of endotoxin and not to the pressure-monitoring or blood sampling 
procedures since saline treatment in SAD and sham rats failed to induce changes in these 
variables. Collectively, these results suggest that arterial baroreceptor disinhibition is not 
the major factor stimulating the sympathoadrenal response to endotoxicosis and suggests 
that non-baroreflex mechanisms may be involved. The profound sympathetic activation 
occurring in the absence of hypotension further supports that hypotension-induced 
baroreflex disinhibition is not essential for sympathoadrenal responses during 
endotoxicosis. 
Although previous studies in conscious rats with intact baroreceptors reported that 
endotoxin-induced sympathetic activation occurred in the presence of hypotension (113), 
sympathetic changes were observed in the absence of significant hypotension in the 
present study. This discrepancy may be attributable to the fact that the animal 
preparations were apparently different between the two studies. The chronic recovery (2-
4 weeks) from a surgery in the present study may somehow altered the blood pressure 
response as compared to acute preparations. The lack of hypotension, however, does not 
limit the examination of the proposed hypothesis since the pattern and magnitude of 
plasma catecholamine response to endotoxin in sham rats were comparable to those 
observed in previous study where hypotension existed (196). Furthermore, decreases in 
barorceptor afferent nerve activity and associated baroreflex deactivation can be induced 
by factors other than hypotension, such as decreases in pulsatile pressure or endothelial 
factors (46,47,70). Although a significant hypotension in the present protocol may 
presumably lead to an even greater elevation in plasma catecholamines, it is also possible 
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that severe hypotension may result in diminished central nervous system function and 
impaired sympathetic outflow. 
Administration of bacterial endotoxin to anesthetized dogs subjected to SAD have 
also been reported by Koyoma et al. (129). Their results showed that endotoxin 
administration induced a fall in both blood pressure and cardiac output with a resultant 
increase in total peripheral resistance in both SAD and sham-operated animals. Such 
increases in total peripheral resistance reflect increased peripheral sympathetic activity 
to peripheral resistance vessels along with decreased cardiac output. In this sense, the 
present results are consistent with their findings. Studies by Mills (159) demonstrated that 
increased sympathetic discharge occurred before endotoxin-induced hypotension in rats, 
indicating that the initiation of sympathetic activation is independent of the baroreflex. 
Following the fall of blood pressure, sympathetic nerve activity increased further and was 
maintained even after blood pressure was restored to basal levels, suggesting that 
maintenance of sympathoadrenal activation is also independent of the baroreflex. Palsson 
et al. (185) observed somewhat similar findings with bolus injection of endotoxin in 
conscious rats in which endotoxin induced a markedly increased renal sympathetic nerve 
activity, that was not diminished after correcting hypotension. 
Additional findings of the present study demonstrate the effectiveness of SAD 
treatment to alter the response pattern of plasma catecholamines to hydralazine-induced 
hypotension. Plasma catecholamines were significantly increased following hydralazine 
in the sham controls but not in the SAD rats during the 30 minute protocol. Thus, SAD 
appears to be an appropriate model to eliminate or significantly blunt the baroreceptor-
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induced sympathoadrenal activation and to test whether such activation occurs during 
endotoxicosis. The increments of plasma catecholamines induced by hydralazine-evoked 
hypotension were far less than that induced by endotoxin administration. Such results 
further suggest that mechanisms other than hypotension-induced baroreflex activation are 
involved in the sympathoadrenal response to endotoxin. 
In both acute and chronic preparations, SAD animals had higher baseline blood 
pressure compared to sham animals. Such relative hypertension is in agreement with most 
of the previous reports (169,239) and may be attributable to the elimination of afferent 
input to the central nervous system, which normally inhibits sympathetic pathways. Thus, 
sinoaortic denervation results in higher basal central sympathetic outflow. In acute 
preparations blood pressures in the sham group were always lower compared to that in 
the SAD group post endotoxin. In an isolated carotid sinus model, Trank and Visscher 
(238) found that the relationship of baroreceptor discharge frequency versus intrasinus 
pressure was shifted to the left during endotoxicosis. Baroreceptor-nerve activity was 
always higher for a given pressure stimulus, which led to a reflex inhibition of 
sympathetic outflow. By denervating arterial baroreceptors, this baroreceptor resetting 
might be eliminated, which could account for the sympathetic outflow being higher in 
SAD rats than in baroreflex intact rats. However, this explanation is unlikely to account 
for the difference in blood pressure following endotoxin between the SAD and sham 
groups, since this difference was not seen in chronic preparations. The most plausible 
factors responsible for the difference between acute and chronic preparations may be cx-
chloralose anesthesia and the acute effect of SAD. Alpha-chloralose anesthesia has been 
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reported to possibly augment baroreceptor reflexes to maintain normal blood pressure 
(39). Acute SAD eliminates the inhibitory baroreflex and results in relative hypertension. 
In the literature conflicting results concerning the HR changes following endotoxin 
have been reported (115,128,137). Both tachycardiac and bradycardic reactions have been 
observed. These different results might be due to differences in animal spices, anesthesia, 
basal HR, and reactive states of the baroreceptor reflex. In the present study HR changes 
induced by endotoxin are not uniform from one preparation to another. In acute 
experiments HR of sham animals was not significantly elevated until 60 and 90 minutes 
post endotoxin, whereas the HR of SAD animals continuously increased with time 
following endotoxin. In chronic experiments, HR was increased with time post endotoxin 
in both sham and SAD animals, but only reached statistical significance in the sham 
group. Since endotoxin-treated SAD rats had higher basal HR compared to sham rats, 
the presence of tachycardia in SAD rats may make a further acceleration undramatic. 
Hydralazine-induced hypotension evoked a sustained tachycardia in sham animals, 
whereas SAD rats exhibited variable changes in HR. 
In conclusion, the data from the present study suggest that the afferent input from 
the arterial baroreceptors is not the major factor, or not even essential, in mediating 
sympathoadrenal activation during endotoxicosis. Non-baroreflexogenic mechanisms may 
be involved in stimulating such activation. 
CHAPTER VI 
RENAL SYMPATHETIC RESPONSE IN SINOAORTIC 
DENERVATED, CONSCIOUS RATS FOLLOWING ENDOTOXIN 
INTRODUCTION 
Endotoxin-induced hypotension and associated baroreceptor reflexes have been 
suggested to be the primary cause of the sympathoadrenal activation during endotoxicosis 
(92,93,148). However, accumulating experimental findings suggest that the 
sympathoadrenal system can be markedly activated by endotoxin or bacteria in the 
absence of significant hypotension (89, 115) and remains activated after restoration of 
blood pressure with volume infusion (159). Results from previous chapter further 
demonstrated that in sinoaortic baroreceptor denervated rats bacterial endotoxin 
administration elevated plasma catecholamines to a similar, if not higher, level compared 
to sham-operated animals (255). These results suggest that the afferent input from the 
arterial baroreceptors is not essential in elevating plasma catecholamines with 
endotoxicosis. Although no hypotension was observed in those animals following 
endotoxin, decreased baroreceptor activity and resultant baroreflex deactivation can be 
evoked by factors other than hypotension (see Chapter V for details). 
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Plasma catecholamines, released from the peripheral sympathetic nerve terminals 
and the adrenal medulla, have been widely used as an index of sympathoadrenal activity. 
However, circulating catecholamine levels can be influenced not only by their release but 
also by neuronal uptake and peripheral catabolism (84), such that increases in plasma 
catecholamines may occur without alterations in catecholamine release (152). Therefore, 
plasma catecholamines may not adequately quantitate sympathetic activity as compared 
to direct nerve recording. Despite the frequent demonstration of an elevation of plasma 
catecholamines during clinical or experimental sepsis, contradictory results have been 
reported with direct measurements of sympathetic nerve activity, i.e. direct nerve 
recordings (127,128,159,185). In addition, differential sympathetic responses have been 
observed during shock states (232,242), such that the sympathetic outflow is increased 
to one organ while decreased to another. Thus, although plasma catecholamines and 
sympathetic discharge both represent the functional state of the sympathoadrenal system, 
they may not always change in a parallel manner. 
Considering these factors as well as the fact that plasma catecholamines and 
sympathetic discharge have never been simultaneously determined in septic animals, the 
present study was conducted. Both plasma catecholamine measurements and renal 
sympathetic recording techniques were employed to assess the contributions of afferent 
neural input from arterial baroreceptors to sympathoadrenal responses in conscious, 
unstrained endotoxic rats. Endotoxin was used as a septic agent based on the large body 
of literature showing that endotoxin administration· to experimental animals duplicates 
many pathophysiological changes observed in patients with sepsis or septic shock 
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(104,122,168,171). To accomplish our objective, conscious rats with either sinoaortic 
denervation (SAD) or intact baroreceptors were subjected to intravenous endotoxin 
treatment. Renal sympathetic nerve activity (RSNA) and circulating catecholamines were 
monitored both before and following the injection of endotoxin. It was hypothesized that 
removal of baroreceptor afferent input would not eliminate the endotoxin-evoked 
peripheral sympathoadrenal activation, as reflected in both the renal sympathetic nerve 
activity and plasma catecholamines. 
100 
MATERIALS AND METHODS 
Experimental Protocols 
Holzman Rats, weighing 396+ 12 grams, were anesthetized with sodium 
pentobarbital (60 mg/Kg, i.p.). Sinoaortic baroreceptor denervation and sham operation 
were performed as described in chapter III. Each animal received 40,000 U penicillin 
(i.m.) following the surgery. After a 2-4 week recovery period, all rats underwent 
surgical implantation of arterial and venous cannulae as well as electrode placement for 
recording renal sympathetic nerve activity under pentobarbital anesthesia (60 mg/kg, 
i.p.). After a 24 hr recovery, cannulae and electrodes were extended to instruments to 
record blood pressure and renal sympathetic nerve activity (RSNA). Following a 0.5 hr 
equilibration period, baroreflexes were tested to confirm the SAD. Endotoxin (5 mg/Kg) 
was then given intravenously to both SAD (n =6) and sham animals (n =7). Separate 
groups of SAD (n=4) and sham {n=5) rats also received equivalent amount of saline for 
time-matched control. Mean blood pressure (MBP), heart rate (HR), and RSNA were 
determined at 0, 5, 15, 30, 60, and 120 min after infusions. Blood samples were taken 
at 0, 15, 90, and 180 min post treatments. 
Sinoaortic Baroreceptor Denervation 
Sinoaortic baroreceptor denervation (SAD) was performed by a method as described 
in chapter III. Briefly, for aortic baroreceptor denervation, the superior laryngeal nerves, 
the superior cervical ganglia including a small segment of sympathetic chain and the 
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aortic depressor nerves were sectioned. For carotid sinus denervation, all connective 
tissue and nerve fibers were stripped from the thyroid, occipital, internal, external and 
common carotid arteries. Sham operation was performed by exposing the carotid sinuses 
bilaterally without dissection of the region. Completeness of baroreceptor denervation 
was tested as described before. 
Sympathetic Nerve Recording 
Renal sympathetic nerve activity (RSNA) was recorded from a renal nerve branch 
of the left greater splanchnic nerve. Briefly, the left kidney was exposed retroperitonealy, 
and the renal nerve branch was found in the aortic-renal artery angle. After the renal 
nerve branch was dissected free the nerve was carefully placed on a thin, bipolar gold 
electrode. When an optimal nerve signal was obtained, the electrode and the nerve was 
fixed with a rubber gel mixture. The electrode wires were exteriorized on the back of the 
neck. On the next day, the electrode wires were extended to the amplifier. The nerve 
signal was amplified 1,000-10,000 fold and filtered (low-frequency cutoff at 35 Hz and 
high-frequency cutoff at 2,000 Hz). Then the amplified signal was full-wave rectified and 
integrated by two separate models of integrator for simultaneous estimation of 
frequencies of RSNA (measured as spikes/min) and overall RSNA (measured as slopes). 
The rectified signal was continuously recorded on a Grass oscillograph. The background 
noise level for the nerve recording was determined 30 min after each animal was killed 
with pentobarbital overdose. All RSNA were expressed as percent of baseline control. 
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Blood Sample Collection and Catecholamine Assay 
Arterial blood samples (500 µL) were collected at different time points as described 
above and assayed for plasma catecholamines using the radio-enzymatic thin-layer 
chromatographic procedure described in general methods. 
Materials 
Endotoxin (derived from S.. enteritidis) was prepared freshly in 0.9% saline (3 
mg/ml). Materials for catecholamine assay were obtained in kit form from Amersham 
(Arlington Heights, IL). Phenylephrine, nitroglycerine and penicillin were purchased 
from Sigma, St. Louis, MO, Baxter, McGaw Park, IL and Pfizer, New York, NY, 
respectively. 
Data Analysis 
Data are expressed as mean+SEM (n). A p value less than 0.05 was considered to 
be statistically significant. Cardiovascular responses, RSNA, and plasma catecholamines 
were compared using analysis of variance with repeated measurements and Student-
Newman-Keul's test for individual comparison. Blood pressure and associated heart rate, 
RSNA responses to phenylephrine or nitroglycerine infusion were compared between the 
SAD and Sham groups with an unpaired Student t test. 
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RESULTS 
Effects of SAD on Baroreflex Control of HR and RSNA: 
Effectiveness of the baroreceptor reflex was tested in all animals. The 
pharmacologic-evoked changes in blood pressure were very transient, lasting only a few 
minutes. Phenylephrine administration induced an identical rise and nitroglycerine caused 
a similar fall of MBP in SAD rats compared to the sham group. The phenylephrine-
induced hypertension was associated with profound bradycardia and inhibition of RSNA, 
and nitroglycerine induced-hypotension evoked significant tachycardia and excitation of 
RSNA in sham-treated animals (figure 6-1 and 6-3). In contrast, SAD eliminated or 
significantly attenuated reflex changes of HR and RSNA in response to those 
pharmacological alterations in blood pressure (figure 6-2 and 6-3). 
Hemodynamic Responses to Endotoxin Infusion: 
The baseline MBP was not different among all animals. SAD and sham rats had 
similar patterns of blood pressure response after endotoxin administration with no 
significant alterations in MBP from control values (figure 6-4). There were also no 
significant differences in baseline HR between SAD and sham animals. Endotoxin 
induced a modest, but not significant, increase in HR in the sham group during the 
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Figure 6-1. Baroreflex test from a conscious sham-operated rat showing blood pressure 
(BP), heart rate (HR), renal sympathetic nerve activity (RSNA) spike and slope responses 
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Figure 6-2. Baroreflex test from a conscious sinoaortic-denervated rat showing blood 
pressure (BP), heart rate (HR), renal sympathetic nerve activity (RSNA) spike and slope 
responses to intravenous phenylephrine (A) and nitroglycerine (B). 
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Figure 6-3. Changes of mean blood pressure (MBP), heart rate (HR), renal 
sympathetic nerve activity (RSNA) spikes and slopes in response to intravenous 
phenylephrine and nitroglycerine in conscious rats with sinoaortic denervation (SAD) or 
sham operation (SHAM). *: p < 0.05 for SAD vs. SHAM. Unpaired-student t test. 
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Figure 6-4. Mean blood pressure (MBP) and heart rate (HR) responses in conscious 
rats with sinoaortic denervation (SAD) or sham operation (SHAM) following intravenous 
endotoxin (ETX, 5 mg/kg) or saline. *: p<0.05 for SAD post endotoxin vs. 0 min; +: 
p<0.05 for endotoxin-treated SAD vs. SHAM. 
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infusion which was maintained for the duration of the protocol. In saline-treated SAD and 
sham rats, there was no alterations in MBP or HR over the course of the experiment. 
Sympathetic Responses to Endotoxin Infusion: 
Endotoxin administration induced very rapid and sustained increases in both RSNA 
and plasma catecholamines. For both SAD and sham groups, RSNA was markedly 
increased as early as 5 min after endotoxin infusion with the peak increase occurring 
between 15-30 min post endotoxin which remained elevated during the protocol (figure 
6-5 and 6-6). RSNA spikes and slopes basically changed in a parallel manner, although 
the magnitudes are not identical. Interestingly, RSNA response at 5 and 15 min post 
endotoxin was 2 fold higher in SAD rats compared to sham rats. Rapid and significant 
elevations in plasma norepinephrine (NE) and epinephrine (BPI) were also apparent at 
15, 90, and 180 min after endotoxin administration in both SAD and sham groups 
compared to baseline values (figure 6-7). Similar to the RSNA response, plasma NE and 
BPI levels at 15 min post endotoxin were also significantly higher in SAD group 
compared to the sham group. Saline-treated SAD and sham rats showed no alterations 
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Figure 6-5. Blood pressure (BP), Renal sympathetic nerve activity (RSNA) spike and 
slope responses to intravenous endotoxin (ETX, 5 mg/kg) infusion from rats with 
sinoaortic denervation (SAD, A) or sham operation (SHAM, B). BN represents 
background noise level. 
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Figure 6-6. Percent changes of renal sympathetic nerve activity (RSNA) spikes and 
slopes in conscious rats with sinoaortic denervation (SAD) or sham 
operation (SHAM) following intravenous endotoxin (ETX, 5 mg/kg) or saline. *: 
p<0.05 for SAD post endotoxin vs. 0 min; #: p<0.05 for SHAM post endotoxin vs. 
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Figure 6-7. Plasma norepinephrine (NE) and epinephrine (EPI) concentrations in rats 
with sinoaortic denervation (SAD) or sham operation (SHAM) following intravenous 
endotoxin (ETX, 5 mg/kg) or saline. *: p < 0.05 for SAD post endotoxin vs. 0 min; #: 




The principal findings of the present study demonstrate a marked elevation in 
sympathoadrenal activity following endotoxin in conscious rats, as indicated by parallel, 
but not identical, changes of direct renal sympathetic nerve recording and plasma 
catecholamine measurements. Such rapid onset and apparently simultaneous increases 
have not been previously reported, and the elevations are of a profound magnitude lasting 
for several hours. Furthermore, since these increments occurred in both sham and SAD 
rats, it suggests that the arterial baroreflex is not essential in mediating such activation. 
The baroreflex control is intact in sham operated rats, as determined by reflex 
bradycardia and sympathoinhibition as well as reflex tachycardia and sympathoexcitation 
in response to pharmacologically induced alterations in blood pressure. With intact 
arterial baroreceptor control of the circulation, intravenous endotoxin administration 
induced rapid and significant increases in both renal sympathetic activity and plasma 
catecholamines. These results further corroborate and also extend previous findings which 
demonstrated significant elevation of plasma catecholamines in different septic models 
of various animal species and septic patients (17,75,113,115,218). The markedly 
increased RSNA in the present study also agrees with the reports from the literature 
showing augmented sympathetic discharge following septic insult in different species 
(93,159,185). Although Koyama et al. reported that efferent sympathetic nerve activity 
in rabbits and cats was decreased following sepsis (127,128), the differences in species 
and the use of anesthesia may account for these observations. 
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In SAD rats, both major arterial baroreceptors, i.e. carotid sinus and aortic arch 
baroreceptors are deafferented. The effectiveness of this treatment is indicated by the 
failure of reflex changes of HR in response to arterial pressure change induced by 
pharmacological agents. Such observations are routinely used as the criteria of the 
completeness of the SAD (8,13,15,169). Direct recording of reflex changes of renal 
sympathetic activity also suggests that baroreflex control of the circulation is greatly 
blunted in SAD compared to intact animals. The significant attenuation in reflex RSNA 
changes in SAD group corresponds to the same directional change of HR. However, the 
degree of attenuation of RSNA changes with vasoconstrictor and vasodilator agents is less 
than that of corespondent HR changes. This observation raises the possibility that the 
cardiomotor component of arterial baroreflex is completely abolished by SAD while the 
vasomotor component of the reflex is not (90). Several lines of evidence suggest that this 
is unlikely. First, we have shown that the same SAD preparation in our laboratory 
significantly abolished reflex elevation of plasma catecholamines in response to 
hydralazine-induced hypotension compared to intact control rats (255), suggesting that 
overall baroreflex-mediated sympathoadrenal activation is disrupted by SAD. Second, we 
and other investigators have observed that SAD markedly potentiates the fall in arterial 
pressure with hydralazine (224,255), indicating that the vasomotor component of 
baroreflexes is also significantly reduced. Third, SAD has been shown to be able to 
eliminate both the cardiomotor and sympathetically-mediated vasomotor components of 
the baroreflex in a parallel manner (90). Taken together, SAD is capable of eliminating 
or significantly blunting the baroreflex-mediated sympathoadrenal activation. The 
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remaining changes of RSNA with arterial pressure alterations may be explained by the 
observation that there is still a selective renal sympathetic activation to pressure changes 
after the baroreflex arc is destroyed. Hubbard et al. (108) reported that plasma renin and 
plasma NE were elevated by hydralazine-induced severe hypotension in rats with nucleus 
tractus solitarii lesion {NTS). These elevations were completely abolished by bilateral 
renal denervation, indicating a selective renal sympathetic activation which is controlled 
by an area lying outside of the NTS, independent of baroreflex arc. Another possibility 
is that cardiopulmonary receptor reflex may mediate the RSNA changes (232). These 
receptors are primarily innervated by vagal nerves and not disrupted by SAD. 
Furthermore, these receptors can differentially regulate sympathetic responses, e.g. 
RSNA versus adrenal sympathetic nerve activity (232). 
After disruption of arterial baroreflex control with SAD, RSNA as well as plasma 
catecholamines were still rapidly and markedly elevated by endotoxin. This result implies 
that the baroreflex does not play a major role in turning on as well as maintaining 
sympathoadrenal activation with endotoxin administration. The significant 
sympathoadrenal activation in association with the absence of hypotension following 
endotoxin in both sham and SAD animals in the present study further supports this 
concept. The explanation for the absence of hypotension following endotoxin in the 
present study may again involve chronic recovery (2-4 weeks) from a major surgery, 
which somehow altered the blood pressure response as compared to acute preparations. 
Interestingly and surprisingly, the sympathetic responses to endotoxin were more 
profound in the early phase in SAD animals compared to sham-operated controls. This 
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heightened response was also accompanied by a greater increase in HR in the SAD group 
versus sham rats. Results from Barron and Heesch (15) may provide a possible 
explanation for the present findings. They demonstrated that baroreceptor denervation 
potentiates the cardiovascular effects and sympathetic outflow elicited by the central 
nervous system activation such as posterior hypothalamic stimulation and 
intracerebroventricular injection of angiotensin II. They proposed that arterial 
baroreceptor reflexes exert an effective buffering of pressor stimuli initiated from the 
central nervous system and that elimination of this buffering mechanism with SAD would 
augment the centrally-mediated cardiovascular and sympathetic responses. It is important 
to recognize that the profound sympathoadrenal responses to endotoxin involve intact 
central nervous system (112) and such responses tend to elevate BP. Analogous to Barron 
and Heesch's finding, this endotoxin-induced, centrally-mediated pressor stimuli also can 
not be buffered in SAD animals, since this modulating mechanism is interrupted with 
SAD. As a consequence, higher RSNA and plasma catecholamine following endotoxin 
are seen in the SAD group. 
The mechanisms responsible for mediating sympathoadrenal activation during 
endotoxicosis can not be determined in the present experiment. Such rapid and profound 
activation may suggest a direct action of circulating mediators on the central nervous 
system during endotoxicosis. Alternatively, rapid peripherally-elicited, centrally-mediated 
reflex mechanisms might be involved. Although local modulation of catecholamine 
release from the adrenal gland has been suggested in endotoxic animals (112,211), more 
studies are needed to determine its importance. It is concluded from the present study, 
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that the sympathoadrenal response to endotoxin infusion is a very rapidly-occurring and 
long-lasting event and that afferent neural input from arterial baroreceptors is not 
essential in mediating such activation during developing septic shock. The elimination of 
feedback buffering mechanisms with SAD may account for the augmented sympathetic 
response seen in SAD animals. More studies need to be done to elucidate the mechanisms 
responsible for this activation. 
CHAPTER VII 
SYMPATHOADRENAL RESPONSES TO CENTRAL ADMINISTRATION 
OF ENDOTOXIN, INTERLEUKIN-1 /3, INTERLEUKIN-6, AND 
TUMOR NECROSIS FACTOR ex IN CONSCIOUS RAT 
INTRODUCTION 
Systemic administration of bacterial endotoxin, as a model of septic insult, results 
in the profound sympathoadrenal activation, as indicated by the direct sympathetic nerve 
recording and plasma catecholamine measurements (93, 113,185). Endotoxin effects are 
recognized to be mediated primarly by the release of cytokines, a family of protein 
molecules produced by macrophages and other cells. Interleukin-1 (IL-1), tumor necrosis 
factor ex (TNF ex), and interleukin-6 (IL-6) have been extensively studied and shown in 
particular to be linked to the pathogenesis of the septic syndrome (37,79). Among the 
multifunctional actions of these cytokines are actions on the central nervous system, some 
of which may be initiated on the brain side of the blood brain barrier. The central effects 
include induction of fever, activation of the hypothalamic-pituitary-adrenal axis, 
suppression of food intake, slow wave sleep, and acute phase response (66,118,194,214). 
The brain site of cytokine actions has been proposed in the hypothalamus (69,194). Brain 
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tissues have receptors for, and can respond direct! y to certain cytokines 
(107,117,194,250). Furthermore, IL-1 immunoreactive innervation has been shown to 
exist in various brain areas including the hypothalamus (34,136), and also some brain 
cells can produce IL-1, TNF and IL-6 in response to endotoxin or inflammatory 
challenge either in vitro or in vivo (82,95, 135,138,200). 
Thus, cytokines might be plausible factors in mediating the sympathoadrenal 
activation with systemic endotoxin via their central actions. To test this hypothesis, 
endotoxin, IL-1, TNF or IL-6 was administered into the lateral ventricle of conscious 
rats, and renal sympathetic nerve activity (RSNA) as well as plasma catecholamine 
responses were assessed. Among the potential brain sites of cytokine effects on the 
sympathetic nervous system, the paraventricular nucleus of the hypothalamus (PVN) is 
a likely candidate. First, the PVN has extensive projections to sympathetic neurons in the 
spinal cord (56) and electrical and chemical stimulations of the PVN increase sympathetic 
outflow and plasma catecholamines (226). Second, electrical activity of neurons in the 
PVN is altered during immune responses (23,205) and the PVN may be involved as an 
IL-1 action site for induction of corticotropin releasing factor (CRF) and pituitary-adrenal 
axis activation (203). Third, IL-1 immunoreactive innervation to the PVN has been 
demonstrated (34,136). Thus, to test whether the PVN is a site of cytokine actions in 
mediating sympathoadrenal response, each of the cytokines was administered to the PVN, 
and sympathetic responses were determined. 
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MATERIALS AND METHODS 
Experimental Protocols 
Holtzman rats, weighing 396+ 12 grams, were used in this study. Under 
pentobarbital anesthesia (60 mg/kg, i.p.), a carotid artery and a jugular vein were 
cannulated with polyethylene tubing. Bipolar, gold electrodes were then implanted on one 
renal branch of the left greater splanchnic nerve for recording renal sympathetic nerve 
activity (RSNA). The ends of cannulae and electrode wires were exteriorized on the back 
of the neck. A final procedure under the anesthesia was to insert a stainless steel cannula 
into the lateral ventricle through the skull or a bilateral cannula to both sides of PYN. 
After a 24 hr recovery, cannulae and electrodes were extended to instruments to record 
blood pressure and RSNA. Following a 0.5 hr equilibration period, endotoxin (ETX, 
1000 ng, n=6), IL-1 {3 (100 ng, n=5, 1000 ng, n=5), IL-6 (100 ng, n=5, 1000 ng, 
n=5), TNF a (100 ng, n=5, 1000 ng, n=5), or saline vehicle (n=5), all in 10 µl 
volume, was administered ICY using a Hamilton syringe. For PYN injection, IL-1 {3 
(1000 ng, n=7), IL-6 (1000 ng, n=5), TNF a (1000 ng, n=6), or saline vehicle (n=5), 
all in 0.5 µl volume, was delivered bilaterally to the PYN. Those doses were chosen 
mostly based on the doses used in previous studies reported in the literature 
(194,202,213). Hemodynamic responses, RSNA and plasma catecholamines were 
assessed at 0, 30, 60, 90, and 180 min post injection. The localizations of the tips of the 
ICY and PVN cannulae were histologically determined at the termination of the 
experiments. 
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In addition, a control group (n =4) was setup to demonstrate a positive sympathetic 
response with PVN injection of a synthetic opioid peptide [D-Ala2 ,NMe-Phe4, Gly-
ol5]enkephalin (DAGO). DAGO, when injected into the PVN, induces catecholamine 
secretion through activation of the central sympathetic outflow to the adrenal medulla and 
sympathetic nerve terminals. Bilateral PVN administration of DAGO (10 µg in 500 nl 
volume) caused significant elevations of RSNA spikes (25+8% at 5 min, 38+ 11 % at 15 
min) and slopes (45+18% at 5 min, 75+5% at 15 min). Saline infusion to the same 
group of rats changed neither RSNA spikes (-1 +3% at 5 min, -2+ 1 % at 15 min) nor 
slopes (-2+4% at 5 min, -1 +4% at 15 min). 
Sympathetic Nerve Recording 
Renal sympathetic nerve activity (RSNA) was recorded from a renal nerve branch 
of the left greater splanchnic nerve, as described in chapter m. After exposing the left 
kidney retroperitoneally, the renal nerve branch was separated from fat and connective 
tissues. It was carefully placed on a thin, bipolar gold electrode. When an optimal nerve 
signal was obtained, the electrode and the nerve was fixed with a gel mixture. The 
electrode wires were exteriorized on the back of the neck. On the next day the nerve 
signal was amplified, rectified and integrated for estimation of frequencies of RSNA 
(measured as spikes/min) as well as overall RSNA (measured as slopes). The integrated 
signals were continuously recorded on a Grass oscillograph. The post mortem renal nerve 
activity was recorded in all animals as a measure of the background noise level. All 
RSNA was expressed as percent change from baseline control. 
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Implantation of Intracerebroventricular (ICV) Cannulae 
Under anesthesia, a 30 gauge stainless steel cannula was implanted into the lateral 
ventricle with the tip stereotaxic coordinates: 0.5 mm caudal to bregma, 1.5 mm lateral 
to the midline, and 4.5 mm below the surface of the skull. The end of the cannula was 
pre-bent to a right angle and connected to a piece of PE-10 tubing (5 cm long), filled 
with saline (3-4 µl) and heat sealed. On the day of experiment, the cannula was extended 
to a 10 µl Hamilton microsyringe filled with test solution. Ten µl test solution (plus 3-4 
µl saline in the cannula) was infused over a period of 5 min. The ICV injection was 
verified by showing ventricular staining after a dye injection via the canula (examples 
shown in figure 7-1). 
Implantation of PVN Cannulae 
Using a stereotaxic apparatus, a 26 gauge bilateral guide cannula comprised of steel 
tubes with a 1.0 mm distance between the centers was implanted to the bilateral PVN. 
The coordinates for PVN were 1.7 mm caudal to bregma, 0.5 mm lateral to the 
midsagital suture and 8.0 mm ventral to the skull surface. A dummy wire with two leads 
was inserted into the guide cannula to prevent clotting and to prevent dust from getting 
into the cannula. On the day of experiments, the dummy wire was removed and a double 
injector cannula (33 gauge) which was constructed 2 mm longer than the guide cannula 
was inserted into the guide cannula. The injector cannula was connected to a 10 µl 
Hamilton microsyringe. A testing solution (500 nl) was injected bilaterally over a 5 min 
period. The exact injection site was histologically verified in each animal at the end of 
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Figure 7-1. Coronal brain sections showing staining of the lateral ventricles after dye 
injection via an intracerebroventricular (ICV) cannula. 
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experiments. Only those animals with the cannula terminated in the dorsal border of the 
PVN without damage of PVN neurons were included in the statistical evaluation 
(example shown in figure 7-2). 
Blood Sample Collection and Catecholamine Assay 
Arterial blood samples (500 µl) were collected at different time points as described 
above. Plasma levels of norepinephrine and epinephrine were assayed in duplicate 50 µl 
samples using the radio-enzymatic thin-layer chromatographic procedure described 
previously. 
Materials 
For ICV infusion, endotoxin, IL-1, IL-6, and TNF were prepared in phosphate-
buffered saline containing 0.2 % bovine serum albumin at a concentration of 10 µg/ml 
for the dose of 100 ng/rat and 100 µg/ml for the dose of 1000 ng/rat. For PVN infusion, 
IL-1 and TNF were prepared in 0.9 % sodium chloride at concentrations of 0.2 mg/ml 
for the dose of 100 ng/rat and 2 mg/ml for the dose of 1000 ng/rat. Saline vehicle 
contained equivalent amount of bovine serum albumin. DAGO was purchased from 
Peninsula, San Carlos, CA. Materials for catecholamine assay were obtained in a kit 
form from Amersham (Arlington Heights, IL). 
Data Analysis 
Data are expressed as mean+SEM (n). A p value less than 0.05 was considered to 
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Figure 7-2. Coronal brain sections at the level of paraventricular nucleus of the 
hypothalamus (PVN). The tips of the cannula were shown to terminate at the dorsal 
border of the PVN. 
125 
be statistically significant. Cardiovascular responses, RSNA, and plasma catecholamines 
were compared using analysis of variance with repeated measurements and Student-
Newman-Keul's test for individual comparisons. 
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RESULTS 
Hemodynamic and Sympathoadrenal Responses to ICV Injection of Endotoxin 
As shown in figure 7-3, ICV administration of endotoxin (1000 ng/rat), given over 
a 5 min period, did not cause significant changes in arterial mean blood pressure (MBP) 
or heart rate (HR) during the 120 min protocol. There were also no significant alterations 
in RSNA, both spikes and slopes, over times following endotoxin. Post treatment plasma 
norepinephrine (NE) and epinephrine (EPI) remained at the levels similar to the controls. 
ICV injection of saline failed to elicit any changes in MBP, HR, RSNA or plasma 
catecholamines. 
Hemodynamic and Sympathoadrenal Responses to ICV injection of IL-1 {3 
As indicated in figure 7-4, neither MBP nor HR was significantly altered by ICV 
administration of low and high doses (100 ng, 1000 ng) of IL-1 {3. These two doses of 
IL-1 induced basically similar patterns of increases in RSNA, as indicated by both spikes 
and slopes. The increments of RSNA were modest, approximately 20-30% of baseline 
values. Peak elevations were reached between 30 to 90 min post injection and remained 
elevated thereafter. In parallel, ICV IL-1 treatment evoked significant elevations of 
plasma catecholamines. Both low dose and high dose of IL-1 elevated plasma NE 
throughout the 180 min protocol. At 60 min, the NE elevation induced by high dose was 
higher than that induced by low dose whereas at 180 min the opposite was seen. Plasma 
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Figure 7-3. Hemodynamic, renal sympathetic nerve activity and plasma catecholamine 
responses to ICV injection of endotoxin (ETX) or saline in conscious rats. MBP: mean 
blood pressure; HR: heart rate; RSNA: renal sympathetic nerve activity; NE: 
norepinephrine; EPI: epinephrine. 
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Figure 7-4. Hemodynamic, renal sympathetic nerve activity and plasma catecholamine 
responses to ICV injection of low and high doses of IL-1 (3 or saline in conscious rats. 
MBP: mean blood pressure; HR: heart rate; RSNA: renal sympathetic nerve activity; 
NE: norepinephrine; BPI: epinephrine. x: p < 0.05 for both low and high dose groups, 
compared with baseline values; # p < 0.05 for low dose group, compared with baseline 
values;*: p<0.05 for high dose group, compared with baseline values; +: p<0.05 low 
dose group vs. high dose group. 
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High dose of IL-1 evoked elevation of plasma BPI at all sampling times during 180 min. 
The increments in BPI evoked by low dose of IL-1 were higher than those induced by 
high dose. 
Hemodynamic and Sympathoadrenal Responses to ICV injection of TNF a 
Neither MBP nor HR was altered within 180 min following ICV administration of 
TNF (figure 7-5). TNF induced significant decrease in RSNA, as indicated by both 
spikes and slopes (approximately 20% ). The pattern of these depressions induced by the 
two doses of TNF were similar to each other. The depression in spikes reached 
significance at 30, 60, 90, and 180 min while the depression in slopes reached 
significance at 60, 90, and 180 min post treatment. Plasma NE or BPI did not change 
significantly following ICV injection of TNF. 
Hemodynamic and Sympathoadrenal Responses to ICV injection of IL-6 
As presented in figure 7-6, ICV injection of IL-6 at doses of 100 ng and 1000 ng 
did not alter MBP or HR significantly. The pattern of RSNA responses, both spikes or 
slopes, to low dose and high dose of IL-6 were quite different from each other. Low 
dose of IL-6 did not change RSNA spikes or slopes at any time post injection whereas 
high dose of IL-6 induced significant depression in both spikes and slopes during the 180 
min sampling period. The peak depression was approximately 20% for RSNA spikes and 
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Figure 7-5. Hemodynamic, renal sympathetic nerve activity and plasma 
catecholamine responses to ICV injection of low or high doses of TNF a or saline in 
conscious rats. MBP: mean blood pressure; HR: heart rate; RSNA: renal sympathetic 
nerve activity; NE: norepinephrine; EPI epinephrine. x: p < 0.05 for both low and high 
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Figure 7-6. Hemodynamic, renal sympathetic nerve activity and plasma catecholamine 
responses to ICV injection of low and high doses of IL-6 or saline in conscious rats. 
MBP: mean blood pressure; HR: heart rate; RSNA: renal sympathetic nerve activity; 
NE: norepinephrine, EPI: epinephrine. *: p < 0.05 for high dose group, compared with 
baseline values; +: p < 0.05 low dose group vs. high dose group. 
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Hemodynamic and Sympathoadrenal Responses to PVN Injection of IL-1 
As shown in table 7-1, PVN injection of IL-1 induced mild but significant elevation 
in mean arterial blood pressure at 60, 90, and 180 min post injection as compared to the 
baseline values. Simultaneously heart rate was slightly but not significantly increased. 
PVN injection of IL-1 had no marked effects on RSNA, both spikes and slopes (table 7-
2). Plasma NE and EPI were slightly elevated at 90 and 180 min after IL-1 injection 
(table 7-3). Plasma NE increased from preinjection value of 331 +45 pg/ml to 520+61 
pg/ml at 90 min and 567+ 103 pg/ml at 120 min. Plasma EPI increased from baseline 
value of 159+23 pg/ml to 349+64 pg/ml at 90 min and 378+59 pg/ml at 120 min. PVN 
injection of saline did not evoke any significant changes in MBP, HR, RSNA, and 
plasma catecholamines. 
Hemodynamic and Sympathoadrenal Responses to PVN Injection of TNF 
There were no significant alterations in blood pressure or heart rate 
following PVN injection of TNF (table 7-1). PVN TNF induced slight ( < 10 %) but 
significant decreases in RSNA slopes at 60, 90, 120 min post injection without significant 
changes in RSNA spikes (table 7-2). PVN TNF had no effects on plasma catecholamines 
(table 7-3). 
Hemodynamic and Sympathoadrenal Responses to PVN injection of IL-6 
As shown in table 7-1, IL-6 injection to PVN induced an increase in HR at 60 min 
without significant alteration in blood pressure. RSNA (both spikes and slopes) and 
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Table 7-1. Effects of saline vehicle, IL-1 {3, TNF a and IL-6 injections into the 
paraventricular nucleus of the hypothalamus (PVN) on mean blood pressure (MBP) and 
heart rate (HR). *: p<0.05 post treatment values vs. baseline value. 
POST TREATMENT MBP {mmH~;u 
Time (min) 0 30 60 90 180 
SALINE 101±1 102±1 105±2 105±2 103±2 
(n=5) 
IL-1 108±3 112±5 116±4* 118±4* 116±4* 
(1000 ng) (n=7) 
TNF 109±3 109±2 110±2 110±2 112±4 
(1000 ng) (n=6) 
IL-6 111±4 111±4 115±8 117±8 115±7 
(1000 ng) (n=5) 
POST TREATMENT HR (beats7min) 
Time (min) 0 30 60 90 180 
SALINE 398±7 388±22 393±21 394±20 401±21 
(n=5) 
IL-1 404±5 411±8 431±10 435±11 436±14 
(1000 ng) (n=7) 
TNF 398±8 415±13 400±16 398±19 400±17 
(1000 ng) (n=6) 
IL-6 420±8 456±21 476±20* 444±22 445±22 
(1000 ng) (n=5) 
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Table 7-2. Effects of saline vehicle, IL-1 (3, TNF a and IL-6 injections into the 
paraventricular nucleus of the hypothalamus (PVN) on renal sympathetic nerve activity 
(RSNA) spikes and slopes in conscious rats. *: p<0.05 post treatment values vs. 
baseline value. 
CHANGE OF RSNA SPIKES l' control! 
Time (min) 0 30 60 90 180 
SALINE 100±0 97±5 97±3 99±3 99±4 
(n=5) 
IL-1 100±0 114±9 99±6 95±7 92±5 
(1000 ng) (n=7) 
TNF 100±0 98±5 96±4 95±3 90±8 
(1000 ng) (n=6) 
IL-6 100±0 96±3 93±2 94±3 100±6 
(1000 ng) (n=5) 
CHANGE OF RSNA SLOPES (% control) 
Time (min) 0 30 60 90 180 
SALINE 100±0 99±3 96±2 99±1 99±1 
(n=5) 
IL-1 100±0 114±9 98±8 97±9 94±10 
(1000 ng) (n=7) 
TNF 100±0 96±2 93±3* 91±2* 92±3* 
(1000 ng) (n=6) 
IL-6 100±0 98±3 97±2 99±4 96±5 
(1000 ng) (n=5) 
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Table 7-3. Effects of saline vehicle, IL-1 [j, TNF ex and IL-6 injections into the 
paraventricular nucleus of the hypothalamus (PVN) on plasma norepinephrine (NE) and 
epinephrine (EPI) in conscious rats. *: p<0.05 post treatment values vs. baseline value. 
PLASMA NOREPINEPHRINE i:e2Lm1 1 
Time (min) 0 30 60 90 180 
SALINE 406±78 423±21 462±21 443±38 456±42 
(n=5) 
IL-1 331±45 430±62 441±48 520±61* 567±103* 
(1000 ng) (n=7) 
TNF 257±47 325±17 319±37 339±27 335±27 
(1000 ng) (n=6) 
IL-6 354±84 372±71 395±95 528±164 360±130 
(1000 ng) (n=5) 
PLASMA EPINEPHRINE (pg7ml) 
Time (min) 0 30 60 90 180 
SALINE 200±41 256±43 217±41 212±33 233±36 
(n=5) 
IL-1 159±23 207±26 256±48 349±64* 378±59* 
(1000 ng) (n=7) 
TNF 123±22 165±18 159±34 162±28 164±31 
(1000 ng) (n=6) 
IL-6 141±17 197±43 166±44 176±54 142±41 
(1000 ng) (n=5) 
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Systemic administration of TNF has been shown to induce modest to marked 
elevation of plasma catecholamines, depending on the doses and animal species used 
(11,53,236). Intravenous treatment of IL-1 has also been demonstrated to evoke slight 
activation of the sympathoadrenal system (21,202). Such activation induced by these two 
cytokines can occur in the absence of hypotension (21,53), which suggests that baroreflex 
mechanisms are not likely to be important in mediating cytokine effects. A variety of 
experimental findings have suggested that many systemic cytokine effects are mediated 
via their actions on the central nervous system (CNS), particularly the hypothalamus 
(194,201). However, the specific mechanisms by which the central cytokines mediate the 
observed increases in sympathetic outflow is not yet known. 
In the present study we investigated the effects of centrally- administered endotoxin 
and cytokines on the sympathetic outflow in order to gain some insight as to the 
mechanism of sympathoadrenal activation during sepsis. The principle findings of this 
study demonstrated that ICV administration of endotoxin did not cause any change in 
sympathetic activity. ICV injection of IL-1 induced a modest activation of the 
sympathetic nervous system where RSNA and plasma catecholamines changed basically 
in a parallel manner. ICV injection of IL-6 or TNF, however, suppressed the RSNA 
without significant alterations in plasma catecholamines. PVN administrations of IL- I 
induced a mild elevation of plasma catecholamines without significant effects on RSNA. 
PVN treatment of TNF slightly decreased RSNA slopes but did not affect plasma 
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catecholmines. IL-6 injection to PVN altered neither RSNA nor plasma catecholamines. 
These results suggest that IL-1 may be one of the mechanisms involved in mediating 
sympathoadrenal activation during septic shock via its central actions, partially in the 
PVN. 
The enhanced catecholamine secretion following ventricular IL- I in the present study 
is in agreement with the previous report by Rivier et al. (202). In their study similar 
doses of ICV IL-1 induced comparable elevations of plasma catecholamines. The 
magnitude of catecholamine increments with ICV IL-1 also resembled that induced by 
systemic IL-1 treatment where higher doses of IL-1 were often used (21,202). The 
augmented sympathetic outflow with IL-1 was further substantiated, in the present study, 
by demonstration of an increased renal sympathetic nerve activity. Although the 
magnitude of the sympathetic response, in this study and in previous study, is apparently 
less compared to the sympathetic activation following systemic endotoxin (93,113), the 
doses of IL-1 used may not reproduce the true local IL-1 concentration in the brain 
parenchyma during endotoxicosis. The time course of ICV IL-1 induced sympathetic 
activation is, however, delayed (peak at 30-90 min) compared to systemic endotoxin 
evoked activation (peak at 15-30 min), even without considering the time needed for the 
synthesis of IL-1 following endotoxin challenge. These differences may suggest that 
either the doses of IL-1 given are not high enough to induce full stimulation of 
sympathetic nervous system or IL-1 is only one of several factors responsible for the 
initiation of the sympathetic activation. At least we can conclude that the 
sympathoadrenal activation during the development of septic shock may be partially 
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mediated by IL-1 via its central actions. 
The mechanisms by which ICV IL-1 leads to the activation of the sympathoadrenal 
system can not be determined in the present study, but an apparent lack of hypotension 
following central IL-1 does not suggest the involvement of cardiovascular reflexes. 
Several other possibilities should also be considered. First, IL-1 may directly affect the 
CNS neurons which control the central sympathetic outflow. The hypothalamus would 
appear to be the most likely area since it has been shown to be involved in many IL-1 
induced central effects such as fever, acute phase response, CRF secretion and 
suppression of food intake (66,118,194,214). Electrophysiological studies show that IL-1 
can directly stimulate hypothalamic neurons to alter the firing rate (107). Furthermore, 
the hypothalamus, particularly the paraventricular nucleus (PVN), is involved in central 
regulation of the sympathetic nerve system (226). However, IL-1 delivery to the PVN 
at concentration higher than achieved with ICV route evoked a smaller and somewhat 
delayed sympathoadrenal response compared to that induced by ICV IL-1. This result 
suggests that other brain areas in addition to the PVN are involved in ICV IL-1 effects. 
Second, pyrogenic effects of IL-1 usually involve activation of the sympathetic nervous 
system in selective organs. However, this is unlikely to be the case in present study 
because IL-1 induced fever usually involves cutaneous sympathetic activation and 
simultaneous renal sympathetic inhibition (204). Although temperature was not evaluated 
in this study, renal sympathetic nerve activity was not decreased but increased. Third, 
centrally administered IL-1 can stimulate the hypothalamus to secrete corticotropin-
releasing factor (CRF) (22,206). Central CRF is known to act within the brain to 
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stimulate sympathetic outflow and result in elevation of plasma catecholamines (38). 
ICV administration of endotoxin has been demonstrated to induce fever production 
(165) and suppression of peripheral immune systems (227). Thus, endotoxin can 
somehow directly interact with the brain elements to cause functional changes. Some of 
the effects can be abolished or attenuated by cyclooxygenase inhibitor or a-MSH 
(165,227). Since prostaglandins have been shown to be the secondary signal of IL-1 
induced fever and a-MSH has anti-IL-I effects, endotoxin effects may indeed be 
mediated by brain-produced IL-1. Studies have shown that IL-1 activity is detected in 
cerebral spinal fluid following central endotoxin administration (54). The failure of ICV 
endotoxin injection to evoke sympathetic activation in the present study does not rule out 
the possibility that brain cells can produce cytokines in vivo. Likewise, the endotoxin-
induced IL-1 may not be sufficient enough to stimulate central sympathetic outflow. 
In contrast to IL-1, TNF (at both high and low doses) significantly suppressed the 
renal sympathetic nerve activity following ICV administration. Previous studies have 
shown that TNF a administered peripherally to rabbits at the dose of 10 µg/kg resulted 
in a decrease in ear temperature, indicative of cutaneous sympathetic activation, and 
simultaneous inhibition of renal sympathetic nerve activity at the initial phase (30 min) 
which returned to control levels around 60 min post treatment (204). The parallel 
changes of renal sympathetic activity following peripheral TNF in this previous study and 
the central TNF in the present study suggest a possible central site of TNF action. The 
much higher dose required for peripheral route as compared to the central route adds 
further support to the notion that TNF effects on renal sympathetic outflow are mediated 
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via its central actions. The longer durations of renal sympathetic suppression in the 
present study may be attributed to high central concentration achieved. A previous study 
using ICY TNF 0t in rats also reported decreased sympathetic activity to the 
interscapular brown adipose tissue (106). The absence of plasma catecholamine changes 
concomitant with depression of renal sympathetic activity may be due to the net results 
of non-uniform alterations of sympathetic efferents to different organs, i.e. sympathetic 
impulse to some organs may be depressed while to others augmented. It should be noted, 
however, that systemic TNF usually induces modest to marked elevations of plasma 
catecholamines (11,53,236) whereas centrally administered TNF, in this study, does not 
affect plasma catecholamine levels. This discrepancy may suggest that either the local 
concentration of TNF in the effective site is not sufficiently high or systemic TNF effects 
on sympathetic nervous system are not exclusively mediated via its central actions. To 
expose brain parenchyma cells to a higher local TNF concentration, TNF was further 
administered directly to PVN, one of the important central regulatory areas for the 
sympathetic nervous system as well as the potential site of cytokine actions. TNF 
injection to PYN induced a slight decrease in RSNA slopes and spikes (the latter was not 
statistically significant), but did not affect plasma catecholamines. The smaller decreases 
in RSNA caused by TNF injection to PYN compared to that induced by TNF injection 
to ICY may indicate that PYN is not likely the only site where TNF acts to induce the 
sympathetic suppression. 
One possible mechanism of central TNF action may be a direct effect on the 
electrophysiology of sympathetic regulatory neurons. TNF has been shown to decrease 
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the transmembrane potential of skeletal muscle (237) and influence the firing rate of the 
neurons in the CNS (180,194). For example, electrophoretically applied recombinant 
human-TNF (rh-TNF) suppressed the activity of glucose-sensitive neurons in the rat 
lateral hypothalamic area (194) and increased neuronal activity of glucoreceptor neurons 
in the rat ventromedial hypothalamic nucleus (180). The ionic mechanism of the 
inhibitory effect of TNF has been proposed to be the inactivation of resting sodium 
conductance (209). A decrease in potassium conductance may underline the excitatory 
effects ofTNF (208). We speculate that ventricularly applied TNF may somehow directly 
or indirectly either stimulate the inhibitory neurons or suppress the excitatory neurons 
in the sympathetic control circuit and results in decreases of the renal sympathetic 
activity. 
Similar to TNF, ICV injection of IL-6, at a high dose, also induced suppression of 
the renal sympathetic activity. The mechanisms of this finding are not known, but 
apparently ICV IL-6 effects on the sympathetic nervous system are not mediated in PVN 
since IL-6 injection to PVN affected neither RSNA nor plasma catecholamines. Previous 
studies have shown that IL-6 has various effects on the central nervous system such as 
fever induction and stimulation of hypothalamic-pituitary-adrenal axis (100,170). IL-6 
induced ACTH release in rats could be abolished by pretreatment with anti-CRF 
antibodies, suggesting that IL-6 effects was mediated via CRF. 
As discussed above, the alterations of sympathetic nerve activity associated with 
PVN injection of either IL-1 or TNF were somewhat delayed and less in magnitude 
compared to those induced by ICV injection of a similar dose of these cytokines. An 
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alternative explaination for this observation is that cytokines injected into the PVN may 
migrate with time to adjacent areas such as cerebral ventricles and thereby cause 
subsequent changes in sympathetic nerve activity. 
Whether cytokines can cross the blood brain barrier and gain direct access to the 
brain parencymal cells is controversial. Generally, it is believed that molecules as big as 
endotoxin or cytokines are unlikely to cross the blood brain barrier. Studies with 
intravenous administration of radiolabled endotoxin and IL-1 have shown inconsistent 
results in terms of detection of radioactivity in the brain (12,20,67, 109). Several authors 
have proposed that cytokines may gain access to the brain, particularly the hypothalamus, 
via circumventricular organs such as organum vasculosum laminae terminalis (OVLT), 
where there is no blood brain barrier (26,116,222). Furthermore, all three cytokines can 
be produced in vivo and in vitro by brain cells such as astrocytes, microglial cells or even 
neurons in response to endotoxin challenge or various other pathological conditions 
(82,95,135,182,200). Recently, Breder et al. reported that IL-1 immunoreactive fibers 
were found innervating the key endocrine and autonomic cell groups and were distributed 
in a manner as to suggest that it functions as a neuromodulator or neurotransmitter 
(34,136). Collectively, the substrates for potential interaction of brain cells with 
circulating, even locally produced cytokine, are possibly present. 
It is not known how much the ventricularly applied cytokines might mimic the true 
exposure of the brain cells to circulating, or even locally produced, cytokines during 
septic states. Considering the normal volume of cerebral spinal fluid (300 µl) and rate 
of secretion (2.2+0.3 µI/min) in the rat, the concentrations of the cytokines at 30, 60, 
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90 and 180 min after ICV injection would be 81, 66, 53, and 28% of the initial amount. 
It is also difficult to estimate how much the timely-diluted cytokines diffuse from CSF 
across the ependymal epithelia and pial surfaces into the brain parenchyma. From 
previous reports on radiolabled peptides and chemicals, after ICV administration, their 
concentrations within the brain target region surrounding the ventricular cavities (e.g. the 
hypothalamus) and subarachinoid space may be less than 2 % of the initial amount. This 
represents less than 20 ng after a dose of 1 µ.g/rat of cytokines without taking enzymatic 
peptide degradation and turnover of CSF into account. Although injection of 1000 ng of 
cytokines into the brain parenchyma seems unphysiological, considering the potential 
local production of cytokines in the brain, an even greater amount of the cytokines than 
that measured in the circulation, i.e approximately 10-s to 10-10 g/ml, may be available 
to neuronal target sites. 
In summary, the present study suggests that the sympathoadrenal activation during 
septic challenge may be partially mediated by IL-1 via its central actions. Furthermore, 
paraventricular nucleus of the hypothalamus appears to be one of the sites mediating 
cytokine induced sympathetic response. 
CHAPTER VIII 
SUMMARY AND CONCLUSIONS 
Sympathoadrenal activation is one of the most dramatic pathophysiological changes 
which occur during septic/endotoxic shock. Such increased sympathetic nerve activity has 
been linked to both beneficial and detrimental effects on the development of the shock 
process. The present dissertation study examined potential mechanisms involved in 
mediating sympathoadrenal activation during experimental endotoxicosis. 
The first project evaluated the overall contributions of central versus peripheral 
mechanisms to the sympathoadrenal activation in endotoxic animals. Specifically, plasma 
catecholamine responses to endotoxin challenge were compared between rats with and 
without central regulatory mechanisms, i.e. conscious and pithed rats, respectively. 
Plasma EPI following endotoxin was further assessed in adrenal denervated conscious and 
pithed rats to illustrate the neurogenic or non-neurogenic characteristics of peripheral 
modulation of adrenal EPI release. 
Summary of results from the first project: 
1. Endotoxin induced a marked elevation in plasma NE in conscious rats, but elevations 
were not seen in pithed rats. 
2. Endotoxin also induced a profound increase in plasma EPI in conscious rats, but 
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increases were much less and delayed in pithed rats. 
3. Plasma EPI elevation following endotoxin was delayed in conscious adrenal denervated 
rats compared to adrenal sham-operated rats. This elevation was approximately one third 
of the maximum response observed in sham controls. 
4. The delayed plasma BPI elevation was also seen in pithed adrenal denervated rats, 
which was not different from that in pithed adrenal intact rats. 
Conclusions drawn from the first project: 
1. The increased plasma NE in response to endotoxin challenge is centrally mediated. 
2. The increased plasma BPI following endotoxin involves both central and peripheral 
mechanisms with the former being dominant. 
3. Peripheral modulation of adrenal BPI release is most likely non-neurogenic, which 
contributes to the prolonged plasma BPI response during endotoxicosis. 
The second project examined the role of afferent neural input from arterial 
baroreceptors in mediating the sympathoadrenal activation during endotoxicosis. 
Specifically, plasma catecholamines and/or RSNA were assessed in anesthetized rats with 
acute SAD and conscious rats with chronic SAD. 
Summary of results from the second project: 
1. Bndotoxin induced a similar, if not higher, elevation in plasma catecholamines in 
anesthetized rats with acute SAD compared to baroreceptor intact sham rats. 
2. Bndotoxin induced rapid and sustained increases in both plasma catecholamines and 
RSNA in conscious rats with chronic SAD. The early increments in plasma 
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catecholamines and RSNA were more profound in SAD rats than sham animals. 
3. Plasma catecholamines were significantly increased by hydralazine-induced 
hypotension in sham rats, but not in SAD rats. This elevation was far less than that 
induced by endotoxin. 
Conclusions drawn from the second project: 
1. Afferent neural input from arterial baroreceptors is not essential in mediating 
sympathoadrenal activation during endotoxicosis, and non-baroreflexogenic mechanisms 
are involved in stimulating such activation. 
2. The elimination of feedback buffering mechanisms with SAD may account for the 
augmented sympathetic response seen in SAD animals. 
The third project tested the hypothesis that cytokines may be involved in mediating 
the sympathoadrenal activation during endotoxicosis, via their actions on the central 
nervous system. Specifically, IL-1, TNF, or IL-6 in addition to endotoxin was 
administered into the lateral ventricle of conscious rats, and plasma catecholamines and 
renal sympathetic nerve activities were assessed. To examine whether the PVN is the 
anatomical site of cytokine actions, each of the cytokines was delivered into the region 
of the PVN, and plasma catecholamines and RSNA were determined following the PVN 
injection. 
Summary of results from the third project: 
1. ICV injection of endotoxin did not significantly change plasma catr..cholamines or 
RSNA. 
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2. ICV injection of IL-1 induced modest increases in both plasma catecholamines and 
RSNA. PVN injection of IL-1 also induced a mild elevation of plasma catecholamines 
without significant effects on RSNA. 
3. ICV injection of TNF resulted in a slight attenuation of RSNA without significant 
effects on plasma catecholamines. RSNA was also slightly decreased following PVN 
injection of TNF without significant alteration in plasma catecholamines. 
4. ICV injection of IL-6 caused decreases in RSNA and no changes m plasma 
catecholamines. PVN injection of IL-6 altered neither RSNA nor plasma catecholamines. 
Conclusions drawn from the third project: 
1. The sympathoadrenal activation during developing septic/endotoxic shock may be 
partially mediated by IL-1 via its central actions while the direct effects of cerebral 
ventricular TNF and IL-6 suppress renal sympathetic activity. 
2. The alterations of sympathoadrenal activity associated with ventricular IL-1 and TNF 
may be mediated, in part, by their actions on PVN. The sympathetic suppression with 
ventricular IL-6 is not likely mediated by actions on PVN. 
The sympathoadrenal activation in response to septic/endotoxic challenge involves 
very complicated processes in peripheral sensory structures, afferent nerves, central 
neuronal networks, efferent sympathetic nerves, and the adrenal medulla. Endotoxin, 
endotoxin-elaborated host factors and various pathophysiological alterations associated 
with septic shock may interact with those neuronal elements at different levels and result 
in enhanced activity of the sympathoadrenal system. 
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As can be integrated from the present study as well as previous works, a schematic 
representation of sympathoadrenal regulation during septic/endotoxic shock is presented 
in Fig. 8-1. Endotoxin, released from the invading gram-negative bacterial wall, 
stimulates macrophages as well as a variety of other cell populations to release cytokines 
and numerous other host factors such as eicosanoids, bradykinin and histamine. These 
factors, particularly cytokines, are important mediators of the hemodynamic, metabolic, 
and neuroendocrine alterations associated with septic/endotoxic shock. 
In terms of neuronal reflex mechanisms, decreased blood pressure and venous return 
with ultimate volume depletion during septic shock may deactivate both arterial 
baroreceptors and cardiopulmonary volume receptors, and reflexly result in increment 
of central sympathetic outflow. Blood borne factors such as epithelial derived factors, 
PGl2, opiates, and neurotensin may also modulate baroreflexes at different levels of the 
baroreflex arc including baroreceptors and NTS (48,49,228,256), which may also lead 
to augmented sympathetic activity. However, marked sympathoadrenal activation could 
occur in septic patients and animals without hypotension or hypovolemia (89,115). 
Alternatively, such activation persists after recovery of hypotension with volume infusion 
(185). Furthermore, profound sympathetic activation is observed in baroreceptor 
denervated endotoxic animals in the present study (255). These results suggest that baro-
and volume- receptor reflexes are not likely to be essential for turning on and 
maintaining the sympathoadrenal activation during septic shock, despite their participation 
in such activation. It is noteworthy that stimulations of mechano- or chemo-sensitive 
nerve endings in abdominal visceral organs also evoke cardiovascular reflexes, which are 
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frequently excitatory (144,145). Such reflexes can be stimulated by passive distension, 
local temperature changes, altering vessel pressure and intraarterial injection or topical 
application of certain chemicals such as bradykinin, histamine and capsaicin 
(144-146,181). Although this reflex mechanism has implications in the sympathetic 
response during septic shock, the importance has not been studied. 
Metabolic alterations associated with septic shock may also be involved in 
sympathetic response. Changes in blood pH as a result of hyperlacticemia and acidosis 
may stimulate peripheral and central chemoreceptors and result in enhanced sympathetic 
outflow. A previous study showed that the plasma epinephrine response to hemorrhagic 
shock was blunted after prevention of acidosis by intravenous administration of sodium 
bicarbonate (58). Insulin-induced hypoglycemia also leads to elevations of plasma 
catecholamines presumably through both neurogenic and non-neurogenic mechanisms 
(120). The neurogenic mechanism likely involves stimulations of gluco-sensitive receptors 
in the hypothalamus and spinal cord (175). Since these metabolic alterations are usually 
delayed processes, they do not appear to account for the rapid onset of sympathoadrenal 
activation during developing septic shock. 
Recently, increasing attention has been drawn to the cytokine-mediated modulation 
of neuroendocrine systems, which is a plausible mechanism for sympathoadrenal 
activation during septic shock. Although cytokines appear unable to cross the blood brain 
barrier in significant quantities, r~ent studies suggest that cytokines may enter the brain 
at sites where blood brain barrier is absent such as OVLT (26,116,222). A further 
possibility is that circulating cytokines can somehow interact with the brain and stimulate 
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its own cytokine productions (34,203). Systemically and centrally administered cytokines, 
particularly IL-1, have been shown to exert many actions in the brain including the 
stimulation of the sympathoadrenal system (53,202,203). This sympathetic activation can 
be evoked by IL-1 via its direct effects on sympathetic regulatory neurons or via some 
secondary neural or humoral factors. For example, IL-1 is a potent endogenous pyrogen 
which can induce fever, and the associated thermogenesis is usually accompanied by 
selective activation of efferent sympathetics and adrenergic mediated vasoconstriction 
(91). IL-1 also stimulates the hypothalamic-pituitary-adrenal axis primarily via releasing 
CRF from the hypothalamus, and CRF has long been recognized to enhance central 
sympathetic outflow (38). PVN seems to be one of IL-1 action sites in evoking 
sympathetic activation. 
Non-neurogenic modulation of adrenal catecholamine release may involve direct 
actions of hypoxia, endotoxin-elaborated endogenous mediators or endotoxin itself on the 
adrenal medulla (166,225). Numerous endogenous substances such as histamine, 
bradykinin, angiotensin II, and vasoactive intestinal polypeptide have been shown to 
stimulate adrenal gland or chromaffin cells to secret catecholamines (130,142,153,177). 
Further studies are needed to determine, in a more systematic and comprehensive 
manner, the role of cytokine mediated modulation of the sympathoadrenal response 
during developing septic shock and the mechanisms underlying this modulation. 
Hypophysectomized animals could be used to determine whether the hypothalamus is the 
primary center of cytokine modulation. Since the OVLT has been proposed to be the 
entry or action site of circulating cytokines to the hypothalamus to mediate their 
152 
pyrogenic effects and hypothalamic-pituitary-adrenal stimulation, experiments with OVLT 
lesions or direct injection of cytokines to OVLT may help understanding the OVLT 
involvement in sympathetic response to endotoxin and cytokines. Electrophoretically 
sampling in a confined hypothalamic area may allow the evaluation of the quantity and 
time course of local cytokine production during endotoxicosis as well as its correlation 
with sympathetic activation. Assessment of sympathetic activity in septic animals after 
application of specific cytokine antibodies to the brain areas suspected to be the cytokine 
production and action sites would provide additional valuable information on central 
cytokine involvements in sympathetic response during developing septic shock. 
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